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ABSTRACT 
Notch deficiency causes arteriovenous malformations  
and altered pericyte function 
 
Natalie M. Kofler 
 
During angiogenesis, nascent blood vessels sprout from pre-existing vasculature and 
recruit pericytes to induce maturation and vessel quiescence.  Perictyes are associated with 
small vessels and capillaries where they share the basement membrane with the endothelium to 
provide vascular support.  Pericytes are a critical component of the blood-brain barrier and 
regulate endothelial cell proliferation, vessel diameter, and vascular permeability.  Endothelial 
cells express Notch1, whereas pericytes express both Notch1 and Notch3.   
Here we show that Notch signaling is essential for pericyte function.  Through genetic 
manipulation and pharmacological tools we show that Notch regulates pericyte recruitment and 
pericyte/endothelial cell interactions.  Notch1+/-;Notch3-/- mutant mice display decreased pericyte 
coverage and altered pericyte association with the retinal vascular plexus.  Notch deficiency is 
associated with vascular anomalies where Notch1+/-;Notch3-/- mice display retinal arteriovenous 
malformations (AVM) characterized by dilated vessels, vascular tangles and arteriovenous 
shunts that are similar to human brain AVMs.  Disruption of pericyte/endothelial cell association 
is accompanied by an increase in vascular density, venule enlargement, and increased vascular 
permeability observed prior to AVM formation.  In the ovary, we show that Jagged is essential 
for pericyte association with the endothelium where inhibition of Jagged-specific Notch 
activation results in luteal vessel dilation and hemorrhaging following ovarian hyperstimulation.  
By in vitro analysis of cultured pericytes we show that Notch1 and Notch3 induce plated derived 
growth factor receptor-β (PDGFR-β) expression to regulate cell migration.  These findings 
expand the role for Notch in angiogenesis by demonstrating that Notch signaling in pericytes is 
essential for vascular development and function. 
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Pericytes in angiogenesis 
The circulatory system develops by two distinct yet intimately related processes: 
vasculogenesis and angiogenesis.  Vasculogenesis occurs first in the developing embryo and is 
initiated when endothelial precursors termed hamangioblasts coalesce and differentiate to form 
a primitive vascular plexus of tubes lined by endothelial cells.  Vascularization of some organs, 
primarily of endodermal origin like the lung and pancreas depends entirely on vasculogenesis1.  
However, the bulk of the circulatory system requires that the primitive vascular plexus formed by 
vasculogenesis be remodeled and expanded through the process of angiogenesis to produce a 
hierarchal vascular network composed of arteries, capillaries, and veins.  Angiogenesis is the 
process by which blood vessels are formed from a pre-existing vascular network2.  This process 
is initiated when the endothelial cells lining the established vessels are exposed to vascular 
endothelial growth factor-A (VEGF-A).  VEGF-A activates its receptor expressed by endothelial 
cells, vascular endothelial growth factor receptor 2 (VEGFR-2) to induce vascular basement 
membrane degradation, cellular proliferation and migration towards increasing concentrations of 
VEGF-A.  Endothelial cells of the angiogenic sprout then undergo lumenization and become 
stabilized through recruitment of mural cells, pericytes and vascular smooth muscle cells.  This 
establishes a stabilized vascular network capable of delivering nutrients and oxygen throughout 
the body of the organism. 
Pericyte recruitment parallels endothelial cell sprouting and migration during 
angiogenesis.  Endothelial cells of angiogenic sprouts secrete platelet-derived growth factor 
(PDGF-B) that functions as a homodimer (PDGF-BB) to activate platelet-derived growth factor 
receptor-β (PDGFR-β).  PDGFR-β is expressed by pericytes and its activation by PDGF-BB 
induces pericyte proliferation and migration to the nascent sprout3,4.  Pericyte association with 
endothelial cells during angiogenesis is essential to induce vascular maturation5.  For example, 
pericyte coverage induces vascular basement membrane deposition to limit endothelial 
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sprouting and promote vascular quiescence6.  The PDGF-B/PDGFR-β signaling pathway is 
critical for pericyte recruitment whereby inhibition of PDGFR-β signaling through genetic 
manipulation or pharmacological inhibition prevents pericyte recruitment to most vascular 
beds7,8.  In the brain, inhibition of pericyte recruitment through genetic deletion of PDGF-B or 
PDGFR-β causes severe vascular dysfunction characterized by increased vessel permeability, 
vessel dilation, and abnormal vessel morphogenesis9.  In the ovarian corpus luteum, inhibition 
of luteal pericyte recruitment causes decreased vascular density and luteal hemorrhaging10.  
During developmental angiogenesis in the retina, inhibition of mural cell recruitment leads to 
vessel dilation, altered vessel patterning, and an abnormal capillary plexus11.  Thus, pericytes 
act as an essential component of angiogenesis by regulating endothelial function to effect 
vessel density, vessel morphology, and to promote vascular maturation. 
 
Defining the pericyte 
To date, studying pericyte function during angiogenesis has proven difficult due to 
limitations in cell marker specificity and pericyte phenotype heterogeneity.  Pericytes have a 
complex ontogeny; different vascular beds are invested by pericytes of different origins.  For 
example, cerebral and retinal pericytes are neural crest derived, whereas pericytes of the 
female reproductive tract are likely of mesodermal origin1,12,13.  Like pericytes, vascular smooth 
muscle cells (VSMC) also have diverse origins2,14.  A current theory proposes that pericytes fall 
along a continuum of mural cell differentiation where pericytes are considered to be a highly 
plastic and immature mural cell as compared to the mature, contractile, and terminally 
differentiated vascular smooth muscle cell3,4,15.  
Bona fide pericytes are found lining capillaries as solitary cells where they share the 
basement membrane with the endothelium (Figure 1)5.  Pericytes display rounded cell 
morphology and extend cell process that at distinct points directly attach to the abluminal 
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surface of the endothelium.  Large arteries and veins are lined exclusively by VSMCs that form 
concentric rings of multiple cell layers, which are physically separated from the endothelium by 
the elastic lamina.  These mature mural cells express contractile proteins, such as α-smooth 
muscle cell actin (αSMA) and smooth muscle cell myosin heavy chain to regulate vessel 
contraction and dilation.  Intermediate-sized blood vessels, such as arterioles and venules, are 
lined by what appears to be an intermediate mural cell type that display features characteristic 
of both pericytes and VSMCs.  Here we define pericytes based on their location within the 
vascular system (lining capillaries, as well as small arterioles and venules), the nature of their 
association with the endothelium (direct contact with endothelial cells through cellular 
processes), and expression of several validated pericyte cell markers (NG2, PDGFRβ, desmin) 
while excluding α-smooth muscle cell actin (αSMA) positive mural cells.  The continuum of 
mural cell differentiation can be clearly appreciated in the mouse retina.  In the mouse retina, 
NG2-positive, αSMA-negative pericytes line capillaries and venules, whereas more mature 
αSMA-positive, NG2-positive mural cells line retinal arterioles (Figure 2).  Based on their 
location and intimate relationship with the endothelium, pericytes fulfill a role distinct from 
VSMCs during angiogenesis and in quiescent vasculature.  Accordingly, it is important that 
pericytes be treated as a cell type independent of VSMCs in order to clearly understand their 
role in angiogenesis and the cellular mechanisms that govern their function.   
   
The Notch signaling pathway 
The Notch pathway is an evolutionarily conserved signaling mechanism that governs cell 
phenotype acquisition in species ranging from worms to mammals6,16.  Notch signaling is highly 
context dependent where it can promote or inhibit cell proliferation, differentiation and cell death, 
as well as govern cell fate determination.  Accordingly, Notch signaling is critical during 
development.  Altered Notch signaling is associated with a variety of diseased states including 
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developmental disorders, such as Alagille Syndrome, adult-onset disorders (for example 
CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy) and cancer17-19.  
In mammals, there are four Notch receptors (Notch1, Notch2, Notch3, and Notch4) 
which can interact with five Delta/Serrate/Lag-2 (DSL) ligands: Delta-like1 (Dll1), Delta-like3 
(Dll3), Delta-like4 (Dll4), Jagged1, and Jagged2.  The Notch receptors and their ligands are 
transmembrane proteins with large extracellular domains20.  Activation of Notch signaling 
requires direct contact between a ligand-presenting cell and a receptor-presenting cell (Figure 
1).  Ligand interaction induces conformational changes of the receptor that exposes a cleavage 
site in the extracellular juxtamembrane region of Notch allowing for ADAM metalloprotease 
cleavage and release of the Notch extracellular domain (Notch-ECD).  Ligand bound to Notch-
ECD is then transendocytosed into the ligand-presenting cell.  In the receptor-presenting cell, an 
additional cleavage event by Presenilin/γ-secretase releases the Notch intracellular domain 
(Notch-ICD) from the plasma membrane allowing it to translocate to the nucleus where it can 
activate transcription.  During canonical Notch signaling, Notch-ICD forms a transcriptional 
complex with CSL (CBF-1, suppressor of Hairless, LAG-1)/RBPjκ and Mastermind-like proteins 
(MAML)21.  Notch-ICD binding to CSL converts CSL from a transcriptional repressor to a 
transcriptional activator by displacing co-repressors and recruiting co-activators.  The 
Notch/CSL/MAML transcriptional complex activates gene transcription through CBF1 binding 
motifs within the promoter of Notch target genes.  Through recognition of CBF1 binding motifs, 
Notch-ICD can activate transcription of a variety of Notch target genes, such as PDGFR-β and 
αSMA22,23.  Notch signaling can also result in indirect repression of downstream targets like 
VEGFR-2 through activation of the transcriptional repressors of the Hairy enhancer-of-split 
(HES) and Hairy/enhancer-of-split related with YRPW motif (HEY) families of basic helix-loop-
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helix proteins24,25.  In this way Notch signaling can evoke direct and indirect transcriptional 
outcomes to regulate cellular function.     
 
Notch signaling in sprouting angiogenesis and mural cell differentiation 
Notch signaling regulates multiple aspects of angiogenesis including endothelial cell 
sprouting, arterial venous specification, and vessel maturation7,8,26.  Notch is essential for 
angiogenesis as evidenced by the vascular phenotypes associated with mutations in Notch 
receptors and ligands (Table 1).  Notch1-/-, Dll1-/-, Dll4-/-, and Jagged1-/- mice die between 
embryonic day 9.5 (E9.5) and 12.5 (E12.5) and display severe cardiovascular defects27-30.  
Notch3-/- mice are viable and fertile despite impaired mural cell maturation and reduced vascular 
tone31,32.  Endothelial cells express Notch1, Notch4, Dll1, Dll4, and Jagged1, whereas mural 
cells express Notch1, Notch2, Notch3 and Jagged133.  At the angiogenic front, Notch functions 
in the endothelium to regulate endothelial cell sprouting by governing lateral inhibition events.  
The endothelial cell leading the angiogenic sprout called the tip cell expresses high levels of Dll4 
in response to VEGFR-2 activation.  Dll4 in the tip cell signals to its neighboring cell called the 
stalk cell through Notch1.  Activation of Notch1 in the stalk cell leads to a down regulation of 
VEGFR-2 expression.  In this way Notch signaling ensures that only the tip cell is highly 
responsive to VEGF-A and thereby limits excessive endothelial cell sprouting.   
During vascular maturation, heterotypic Notch signaling between the endothelium and 
mural cells, as well as homotypic Notch signaling between mural cells induces mural cell 
differentiation and thus vessel maturation.  Notch signaling in vascular smooth muscle cells 
activates expression of contractile proteins and thus promotes vascular smooth muscle cell 
differentiation to a mature and contractile cell phenotype32,34,35.  During development, Jagged1 
expression by endothelial cells is required to activate expression of contractile proteins in 
VSMCs to induce their maturation36,37.  In adult mice, Notch3 signaling maintains mural cell 
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coverage in the brain, retina, and tail and Notch3 signaling is essential for proper vessel 
tone34,38,39.  
Alterations in Notch signaling are implicated in cerebral vascular pathologies, including 
CADASIL and arteriovenous malformations.  Inherited mutations in Notch3 cause the lethal 
stroke disease CADASIL, which is characterized by Notch3-ECD cellular aggregates, loss of 
cerebral mural cell coverage, and deregulation of cerebral blood flow18,40,41.  Arteriovenous 
malformations are also associated with abnormal Notch signaling42.  Arteriovenous 
malformations (AVM) are abnormal cerebral vessels that shunt arterial blood directly into 
venous circulation without the normal intervening capillary plexus43.  This direct transfer of blood 
results in increased hemodynamic pressure in the AVM and an increased risk of hemorrhage, 
and death.  Endothelial activation of Notch signaling has been implicated in arteriovenous 
malformations in mice and in the human brain42,44,45.  Dysplastic vessels in brain AVMs and 
human venous malformations also display disorganized and reduced αSMA positive mural cell 
coverage, suggesting that loss of proper mural cell coverage or function may contribute to 
vascular malformations46-48.    
Since both pericytes and the Notch signaling pathway critically regulate angiogenesis 
and pericytes express Notch receptors, we hypothesized that Notch functions in pericytes to 
regulate angiogenesis.  Using the mouse retina and the ovarian corpus luteum as models of 
angiogenesis, we show that Notch is critical for pericyte recruitment to nascent blood vessels 
and that Notch signaling regulates pericyte association with the endothelium.  Furthermore, we 
demonstrate that Notch-regulated pericyte/endothelial cell association is essential for 
endothelial function during angiogenesis.  We show that loss of Notch signaling in pericytes 
alters vascular density and causes venule enlargement, increased vascular permeability, and 

































Figure 1. Diversity of mural cell phenotypes. Bona fide pericytes are found lining capillaries.  
Boxed region of capillary cross section shows that pericytes (P) make direct contact with endo-
thelial cells (E) and share a basement membrane with the endothelium.  Figure adapted from 
Armulik, A., Genové, G., & Betsholtz, C. (2011). Pericytes: developmental, physiological, and 
pathological perspectives, problems, and promises. Dev Cell, 21(2), 193–215.
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Lectin / NG2 / αSMA
Figure 2. Mural cell marker expression in the retina. In P5 mouse retinas, only the mural 
cells lining the arterioles express αSMA (red). Pericytes lining the capillaries and venules 
express NG2 (green) and are negative for αSMA. In the retina, pericytes are also desmin 
positive and PDGFR-β positive (staining not shown). This staining pattern is maintained in 





















Figure 3. The Notch signaling pathway. The Notch receptor is first produced as a precur-
sor proteint that undergoes furin cleavage at the S1 site to yield the Notch extracellular 
domain (ECD) and Notch intracellular domain (ICD), which contains the transmembrane 
(TM) domain (S1 cleavage is not shown in this diagram). At the cell surface, Notch-ECD and 
Notch-ICD are non-covalently linked. Ligand interaction allows for proteolytic cleavage at the 
S2 cleavage site by ADAM secretase followed by γ-secretase mediated cleavage at the S3 
site. S3 cleavage releases Notch-ICD from the plasma membrane to enable its translocation 
to the cell nucleus where it activates transcription as part of the CSL/MAML/Notch-ICD 
transcriptional complex. EGF; epithelial growth factor, DSL; Delta/Serrate/LAG-2; LNR; 
Lin12-Notch repeats, RAM; RBPjκ association module, NLS; nuclear localization signal, 
PEST; proline/glutamic acid/serine/threonine-rich motif, CSL; CBF1/RBPjκ/Su(H)/Lag-1, 





























Table 1.  Cardiovascular phenotypes of Notch mutant mice 
 
Gene Genetic Manipulation Cardiovascular Phenotype Reference 
Notch1 
Global null 
Lethal prior to E11.5. Impaired angiogenesis: 
reduced sprouting, reduced remodeling.  
Collapsed aorta and cardinal vein.  This 
angiogenic phenotype is worsened with 
additional loss of Notch4. 
27,49,50 
Endothelial loss of function Decreased aortic diameter. Arteriovenous malformations 
51 
Global gain of function Impaired vascular remodeling. Increased aortic diameter. Arteriovenous malformations. 
51 
Notch2 
Global (hypomorphic) null 
Lethal perinatally. Impaired kidney glomerular 
vascular development, myocardia hypoplasia, 
abnormal hyaloid vasculature. 
52 
Cardiac neural crest  
loss of function 
Reduced cardiac smooth muscle cell coverage. 




Viable. Reduced VSMC maturation, impaired 
arterial VSMC specification, disrupted arterial 
structure. Loss of retinal VSMC coverage. 
Reduced vessel branching and outgrowth.  
32,38,54 
R169C Notch3 mutation 
Display cerebral vascular abnormalities 
reminiscent of CADASIL. Notch3-ECD 
aggregates, disrupted VSMC coverage, 
reduced vessel caliber and cerebral blood flow. 
31 
Global null 
(combined with Notch2 null) 
Lethal at E11.5. Decreased VSMC coverage 
with vessel collapse.   
55 
Notch4 
Global null Viable. No observed vascular defects. 27 
Endothelial gain of function 
Lethal at E10. Impaired vessel branching, 
disorganized vascular networks, enlarged 




Lethal at E12. Display severe hemorrhaging.  
Increased venous identity with decreased 
arterial identity. 
29 




Lethal at E9.5. Loss of arterial endothelial 
identity. Defects in arterial branching and 
vessel remodeling.   
30,58 
Global heterozygote Viable. Increased vascular density and branching in the retina. 
59 
Gain of function 
Lethal prior to E10.5. Increased diameter of the 
dorsal aorta, decreased vascular sprouting, 
increased perivascular fibronectin deposition.   
60 
Jagged1 
Global null Lethal at E11.5-E12. Display severe hemorrhaging, defective vascular remodeling. 
28 
Endothelial loss of function 
(Constitutive) 
Lethal at E11.5-E12. Impaired VSMC 
maturation, cranial hemorrhaging, impaired 
vascular remodeling. 
36 
Endothelial loss of function        
(Induced postnatally) 
Viable. Reduced retinal vascular density with 




























The mouse retina as a model of angiogenesis 
In the mouse, the retina becomes vascularized postnatally through the process of 
angiogenesis.  in utero, angiogenesis produces the choroid vascular plexus, which supplies the 
outer layers of the retina with nutrients and the temporary hyaloid vascular network, which 
provides in utero support to the inner eye.  Immediately following birth, retinal angiogenesis is 
driven by hypoxia which induces the astrocyte plane that lines the inner surface of the retina to 
secrete VEGF-A61.  Endothelial cells sprout out and away from the optic nerve and along the 
inner surface of the retina to form a primary vascular plexus that reaches the periphery of the 
retina by postnatal day 8 (P8) (Figure 1).  Endothelial cells then continue to sprout and migrate 
deeper into the retinal tissue to form a secondary and intermediary vascular plexus.  
Vascularization of the retina is completed by P21 in the mouse and follows tight temporal 
regulation.  The consistent temporal regulation of retinal angiogenesis makes it an ideal model 
for studying various aspects of angiogenesis.  Analysis of retinas isolated at P5 allows for 
assessment of angiogenic sprouting by measuring vascular density.  Assessment of retinal 
vasculature at P8 can demonstrate vascular maturation events, whereas vascular function can 
be determined at later time points in development, such as P13.  
 
Animals 
Transgenic Notch reporter (TNR) mice harboring an enhanced GFP sequence under the 
control of 4 tandem copies of the CBF1 binding site consensus sequence were obtained from 
Jackson Laboratories62. Notch1 and Notch3 mutant mice have been previously described49,54.  
Please refer to Table 1 for genotyping primers.  For ovary studies, female wildtype C57/Bl6 mice 
of 3 weeks of age (+/- 3 days) were obtained from Jackson Laboratories.  Pregnant mare 
gonadotropin (Sigma) and human chorionic gonadotropin (Sigma) was used for stimulation of 
folliculogenesis and ovulation, respectively.  All procedures were carried out according to 
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approved protocols and guidelines established by the Columbia University Institutional Animal 
Care and Use Committee.  
 
Immunohistochemistry on Retinal Wholemounts 
Following sacrifice, eyes were enucleated and fixed in 4% PFA for 2 hours at 4°C.  
Retinas were then dissected out and incubated in 0.5% Triton-X-100, 1% BSA, overnight at 4°C.  
Following washes in PBLEC (1% Triton-X-100, 1mM MgCl2, 1mM MnCl2, and 1mM CaCl2 in 
PBS [pH 6.8], retinas were incubated overnight in PBLEC containing biotinylated Isolectin-B4 
(VectorLabs, 1:50) plus additional primary antibodies at appropriate dilutions (Table 2).  On the 
following day, retinas were washed 3 times with PBLEC for 30 minutes each wash, and then 3 
times with PBLEC diluted by half with 1XPBS (PB/2) for 30 minutes each wash.  Retinas were 
incubated with Alexa Fluor conjugated secondary antibodies (Invitrogen) diluted at 1:500 in PB/2 
overnight at 4°C or for 2 hours at room temperature while shaking.  Retinas were then washed 4 
times for 15 minutes each wash in PBLEC diluted by ¼ with 1xPBS (PB/4) followed by a single 
10 minute wash with 1XPBS.  To ensure longevity of staining retinas were post-fixed with 4% 
PFA for 15 minutes at room temperature.  Retinas were then washed several times with 1XPBS 
prior to mounting on slides with mounting media containing 90% glycerol in 0.1M Tris pH 8 and 
1 μg/ml of Hoechst nuclear stain (Sigma).  
 
Latex Bead Perfusion Assay 
The latex bead perfusion was performed as previously described63.  Briefly, neonatal 
mouse pups were given a lethal dose of anesthesia (ketamine/xylazine).  The abdominal and 
thoracic cavities were opened, the left and right atria were snipped, and a solution of blue latex 
beads (Connecticut Valley Biological Supply Company) was slowly injected into the left ventricle 
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of the heart.  The eyes were then enucleated and processed for retinal wholemount 
immunostaining.   
 
Analysis of Hyaloid Vasculature 
Following sacrifice, eyes were enucleated and fixed with 4% PFA for 2 hours at 4°C and 
then washed with 1X PBS.  Under a dissecting microscope the cornea, sclera and retina were 
dissected away.  The hyaloid artery was cut at the optic nerve and the lens and hyaloid were 
kept intact and removed.  The retinal wholemount immunostaining protocol was used to stain 
the hyaloid, aside from the mounting procedure.  Instead the hyaloid and lens was kept in a 48-
well the dish following post-fixing and low magnification confocal images were obtained using a 
Nikon A1R microscope by taking stacks through the entire lens. 
 
Ovary Preparation and Staining 
Following sacrifice, ovaries were removed and weighed after the fallopian tube was 
carefully removed and discarded.  Ovaries were fixed with 4% PFA for 2 hours at 4°C and then 
dehydrated in 30% sucrose overnight at 4°C.  Following sucrose dehydration ovaries were 
embedded in OCT for sectioning. Hematoxylin and eosin staining was performed by following an 
adjusted standard protocol where slides were incubated for 1 minute in hematoxylin and an acid 
wash was not performed.  For ovary immunohistochemistry of thin sections, 7 μm ovary 
sections were fixed and permeabilized with acetone.  Sections were then incubated for 1 hour in 
blocking solution containing 3% bovine serum albumin and 2% donkey serum.  Ovaries were 
then incubated overnight at 4°C in blocking solution containing appropriate amounts of primary 
antibody (see Table 2).  After washing in 1XPBS, ovary sections were then incubated for 1 hour 
at room temperature in blocking solution containing Alexa Fluor conjugated secondary 
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antibodies (Invitrogen) diluted at 1:1000.  Vectashield® mounting medium with DAPI (Vector 
Laboratories) was used to visualize nuclei.   
 
Validation of Serum Decoy Levels 
For analysis of serum decoy levels prior to ovary collection blood was isolated from the 
tail vein.  For analysis of serum decoy levels at time of ovary collection, blood was isolated by 
cardiac puncture.  Blood was then centrifuged at maximum speed for 5 minutes to separate out 
the plasma.  Plasma was frozen at -20°C until time of use.  2 μl of serum was run on SDS-
PAGE by standard protocol.  Human Fc was detecting using a HRP-conjugated antibody 
against human Fc (Sigma; A0170) at a dilution of 1:5000 in 2% milk, 2% BSA, 0.1% Tween in 
PBS.     
 
Image Acquisition 
A Nikon A1R microscope was used to acquire confocal stacked images of the stained 
and flat-mounted retinas.  Brightfield colored tiled 5X images of latex perfused retinas were 
obtained using a PALM MicroBeam IV Laser Capture, Microirradiation, Histology Inverted 
microscope.  Corresponding fluorescent 10X tiled confocal stacks were obtained using a Nikon 
A1R microscope.  A Nikon Eclipse 200 fluorescent microscope and a Nikon A1R confocal 
microscope was used to obtain images of fluorescently stained images of ovary sections.  
Imaging of cultured cells was achieved using a Zeiss Axiovert 40 CSL inverted microscope.  
ImageJ and Adobe Photoshop were used for image processing.    
 
Vessel Density and Pericyte Coverage Quantification 
ImageJ was used for all quantification.  For retinal vessel density quantification, 10X 
stacks were taken of each leaflet of each retina.  The vascular area was outlined and then the 
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percent coverage of Isolectin-B4 staining of total vascularized area was obtained by 
thresholding the image.   A similar procedure was performed for each leaflet stained with NG2 to 
analyze pericyte content per vascularized area.  Pericyte coverage was calculated by dividing 
percent area of NG2 by percent area of Isolectin-B4.  Vessel outgrowth was quantified by 
measuring the distance from the optic nerve to the edge of the vascular front for each leaflet.  
No significant difference in body weight was observed between genotypes (data not shown).  
For ovarian analysis, merged 10X stacks were obtained to cover the entire ovary section and 
account for changes in the focal plane.  Each corpus luteum was outlined by hand.  For each 
corpus luteum, thresholding was used to quantify corresponding total cell content by DAPI 
staining, endothelial cell content by CD31 staining, and pericyte content by NG2 staining.  
 
Statistical Analysis 
Data is presented as standard error of the mean or standard deviation, as indicated.  
Statistical significance was assessed using two-tailed student t-test.  P-values less than 0.05 
were considered significant.  All data represents three independent experiments, unless 
otherwise noted.   
 
Cell Culture 
All cell cultures were maintained at 37°C in a mixture of 5% CO2 and 95% humidified air. 
Human umbilical vein endothelial cells (HUVEC) were isolated as described and grown in EGM-
2 Endothelial Cell Growth Media (CC-3162; Lonza Group)9,64.  Human brain vascular pericytes 
(HBVP) (ScienCell) were maintained in 1X Low Glucose DMEM with 10% fetal bovine serum 
(FBS) and 1X Pen-Strep (100 U of penicillin and 100 U of streptomycin (Invitrogen).  The 
gamma-secretase inhibitor (GSI) compound E was obtained from Korean Research Institute of 
Chemical Technology, an equal volume of DMSO (sigma) was used as control.   
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 Adenovirus Infection of Cultured Cells 
1.5 million cells were infected in suspension for 1 hour with adenovirus (MOI of 25).  Adenovirus 
infection was halted by the addition of serum and cells were then plated.  RNA was collected 48 
hours after infection for analysis.   
 
Production and Assessment of Stable Cell Lines 
Cells with Notch activation and knockdown cell lines were made using stable lentiviral 
infection.  Lentivirus was produced by 293T cells that were calcium phosphate transfected with 
viral packaging vectors with appropriate lentiviral constructs.  For Notch activation 293T cells 
were transfected with 10 ug of pccl-GFP, pccl-RFP, pccl-Fc, pccl-N1IC, pcclN3IC, or pccl-
N4/int3.  For Notch knockdown experiments 293T were transected with 5 μg plko-empty vector 
plus 5 μg plko-scrambled shRNA, or 5 μg plko-NOTCH1 shRNA, or 5 μg plko-NOTCH3 shRNA, 
or plko-NOTCH1 shRNA and plko-NOTCH3 shRNA for double knockdown.  To make stable cell 
lines, 293T supernatant containing virus was passed through a 0.45 μm filter and added to 
target cells (HUVEC or HBVP).  All knockdown constructs were obtained from Sigma and 
validated by quantitative RT-PCR.  Protein lysate was collected 4 days post-infection in TENT 
lysis buffer containing 1X HALT protease inhibitor cocktail (Thermo Fisher).  The following 
antibodies were used for western blotting in 2% milk, 2% BSA, 0.1% Tween in 1X PBS: Rabbit 
anit-NG2 (1:1000) (Millipore), Rabbit anti-PDGFRβ (1:1000) (Cell Signaling), mouse anti-






Gene Expression Analysis 
RNA was collected from cultured cells using the RNeasy Mini Kit  (Qiagen). Isolated 
RNA was treated with DNase1 for 30 minutes and then used in reverse-transcription PCR using 
the Verso™ Reverse Transcriptase kit with random hexamers to prime cDNA (Thermo Fisher).  
For quantitative RT-PCR, the reactions were done in triplicate with ABsolute Blue QPCR SYBR 
Green ROX Mix (Thermo Scientific) using a 7300 Real-Time PCR System (Applied Biosystems).  
Standard PCR to assess relative gene expression levels were performed by amplifying cDNA 
using specific primers and Platinum Taq Polymerase (Invitrogen).  PCR amplification was 
performed with 35 cycles.  See Table 3 for PCR primer sequences.   
 
PDGF-BB Directed Matrigel Migration Assay 
20 μl of matrigel (BD Biosciences) diluted 1:6 with serum free DMEM media was added to a BD 
Falcon™ cell culture insert for a 24 well plate with a pore size of 8 μm.  600 000 HBVP were 
seeded on matrigel in serum free DMEM containing 200 μM compound E or DMSO as control.  
Serum free DMEM containing 20 ng/ml of human recombinant PDGF-BB (R&D Systems) and 
0.1% BSA (sigma) for stabilization was added to the lower chamber.  After 48 hours the matrigel 
was removed and the side lining the filter was stained with toluidine blue to visualize cell 
content.  It should be noted that due to time constraints this experiment was only performed 
once. 
 
Pericyte/Endothelial Cell Co-culture Assay 
The endothelial cell/pericyte co-culture assay was performed as previously described65.  
Briefly, HUVEC and HBVP at a concentration of 1x107 cells/ml were embedded in 2.5 mg/ml 
collagen gel at a ratio of 5:1, HUVEC:HBVP.  200 ng/ml of SCF (R&D Systems), IL-3 (R&D 
Systems), and SDF-1α (R&D Systems) was added to the collagen gel prior to its solidification.  
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The collagen gel containing endothelial cells and pericytes was allowed to solidify at 37°C for 30 
minutes in a half-volume 96-well plate prior to the addition of EGM-2 media to the well.  Due to 

















































Figure 1. Developmental retinal angiogenesis in the mouse. Arrows depict endothelial tip 
cells. Adapted from Gerhardt, H., et al. (2003). VEGF guides angiogenic sprouting 


























Table 1.  Genotyping primers 
Primer Sequence (5' to 3') 
TNR Forward TGCCCTTTCCTTAAAAGTGG 
TNR Reverse GCCTACTCCGACACCCAATA 
Notch1 Mutant Forward CAGGGGTTGGAGAGACATTCATTG 
Notch1 Mutant Reverse TCGCCTTCTATCGCCTTCTTG 
Notch1 Wildtype Forward TCTAAGTGCTCCGAGGAGATCA 
Notch1 Wildtype Reverse CAGGGGTTGGAGAGACATTCATTG 
Notch3 Mutant Forward TCGCCTTCTATCGCCTTCTTG 
Notch3 Mutant Reverse GGTACTGAGAACCAAACTCAG 
Notch3 Wildtype Forward CCATGAGGATGCTATCTGTGAC 



















Table 2.  Antibodies for immunohistochemistry 







CD31 Rat BD Biosciences 553370 1:100 1:500 
NG2 Rabbit Millipore AB5320 1:750 1:750 
NG2 Rat R&D Systems MAB6689 1:500 1:500 
Desmin Rabbit Abcam AB15200 1:500 1:500 
PDGFR-β Rabbit Cell Signaling 3169 1:500 1:500 
αSMA-Cy3 Mouse Sigma C6198 1:750 1:1000 
GFP Rabbit Abcam AB6556 1:1500 N/A 
Collagen Type 4 Rabbit Cosmo Bio LSL-LB-0445 1:500 N/A 
Laminin Rabbit Abcam Ab81813 1:500 N/A 
Fibronectin Rabbit Abcam AB23750 1:500 N/A 
Notch1 Goat R&D Systems AF1057 N/A 1:200 
Notch3 Rabbit Abcam AB60087 N/A 1:100 

















Table 3. Primers for mRNA expression analysis  
Gene Forward Primer (5' to 3') Reverse Primer (5' to 3') 
β-ACTIN CGAGGCCCAGAGCAAGAGAG CTCGTGATGGGCACAGTGTG 
DLL4 CGGGTCATCTGCAGTGAAAC AGTTGAGATCTGGTCACAAAACAG 
GAPDH GCCAAAAGGGTCATCATCTC GTAGAGGCAGGGATGATGTTC 
HES1 CCCAACGCAGTGTCACCTTC TACAAAGGCGCAATCCATATG 
HES5 TCGCCTCGTCGCCTGTTC CCACGAGTAGCCTTCGCTGTAG 
HEY1 ACGAGAATGGAAACTTGAGTTC AACTCCGA AGTCCATAGCAAG 
HEYL CAGGATTCTTTGATGCCCGAG GACAGGGCTGGGCACTCTTC 
JAGGED1 GCTTGGATCTGTTGCTTGGTGAC ACTTTCCAAGTCTCTGTTGTCCTG 
JAGGED2 GCTATTTCGAGCTGCAGCTGAG GCGGCAGGTAGAAGGAGTTG3 
NOTCH1 (ECD) GCAGACTATGCCTGCAGCTG GCCACACTCGTTGACATCCTG 
NOTCH1 (ICD) CTCACCTGGTGCAGACCCAG GCACCTGTAGCTGGTGGCTG 
NOTCH2 CAGTGTGCCACAGGTTTCACTG GCATATACAGCGGAAACCATTCAC 
NOTCH3 CGCCTGAGAATGATCACTGCTTC TCACCCTTGGCCATGTTCTTC 
NOTCH4 (ECD) ATGACCTGCTCAACGGCTTC GAAGATCAAGGCAGCTGGCTC 
PDGF-B TGCTACCTGCGTCTGGTCAG ACACCAGGAAGTTGGCGTTG 









































During angiogenesis, vascular maturation requires mural cell recruitment and 
association with nascent blood vessels.  Mural cells include contractile vascular smooth muscle 
cells (VSMC) and pericytes, which share the basement membrane with the endothelium.  
Pericytes are mural cells associated with small caliber blood vessels and capillaries that 
regulate endothelial cell proliferation, lumenization, and vascular basement membrane 
formation6,9,66.  The platelet-derived growth factor (PDGF)-B/PDGF receptor-β (PDGFRβ) 
signaling pathway is critical for vascular pericyte recruitment and coverage in the central 
nervous system (CNS) and subsequent blood-brain barrier formation and function9,67-70.  Lack of 
pericyte coverage in the CNS, including the retina, causes endothelial cell hyperplasia, vessel 
dilation, and increased vascular permeability11,69,70.  
The Notch signaling pathway regulates endothelial cell function and vessel maturation 
during angiogenesis.  Specifically, Notch signaling regulates endothelial cell sprouting, 
arteriovenous specification, and VSMC maturation26,71,72.  Notch signaling requires direct cell 
contact for receptor activation.  Upon ligand binding, proteolytic cleavage events release the 
Notch intracellular domain from the plasma membrane allowing it to translocate to the nucleus 
to activate gene transcription (See Chapter 1 for detailed review).  In VSMCs, Notch1 and 
Notch3 induce expression of genes important for mural cell function.  In human aortic smooth 
muscle cells, Notch promotes α-smooth muscle cell actin (αSMA) expression22.  In VSMCs 
isolated from human coronary arteries, Notch induces PDGFR-β expression22,23.  Mice deficient 
for Notch3 and mice with endothelial-specific knockout of Jagged1 have normal pericyte 
recruitment, but impaired vascular smooth muscle cell coverage and maturation along larger 
vessels36-38.  In these mouse models, decreased Notch signaling in the mural cell compartment 
was associated with vessel dilation and altered angiogenesis, suggesting that Notch signals in 
mural cells to regulate vessel function.  
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Notch signaling has also been implicated in the development of arteriovenous 
malformations (AVMs)42,44,45.  Furthermore, mouse models that recapitulate human brain AVMs 
display vessel dilation and increased capillary density in areas of localized cerebrovascular 
malformations consistent with phenotypes associated with decreased CNS vascular mural cell 
coverage46.  Thus, AVMs may involve both endothelial cell and mural cell dysfunction. 
In the vasculature, endothelial cells and mural cells express Notch1, whereas Notch3 is 
restricted to the mural cell compartment. Given that Notch1 and Notch3 are expressed by 
pericytes, and that pericytes critically regulate angiogenesis, we sought to analyze angiogenesis 
in mice with combined deficiencies of Notch1 and Notch3.  Specifically, we studied Notch3 
mutant mice and Notch3 nulls with Notch1 haploinsufficiency.  By analyzing the developing 
mouse retina in these mice we found that Notch1+/-;Notch3-/- mice displayed increased vascular 
density, vessel dilation, and increased vascular permeability.  Notch1+/-;Notch3-/-  mice also had 
arteriovenous malformations in the retina that were characterized by arteriovenous shunts and 
vascular tangles that resembled the structure of human brain AVMs.  
 
RESULTS 
Loss of Notch3 with Notch1 insufficiency results in increased vascular density and 
venule enlargement in the retina. 
Loss of Notch1 activity results in a hypersprouted retinal vasculature, presumably due to 
endothelial dysfunction59,73,74.  Notch3 mutant mice display reduced mural cell coverage and 
maturation32,38.  However, both Notch1 and Notch3 are expressed by pericytes (Figure 1) and 
one can hypothesize that proper pericyte function may depend on the combined activity of 
Notch1 and Notch3.  We generated viable mice null for Notch3 and heterozygous for Notch1, 
Notch1+/-;Notch3-/- mice, to explore how these two Notch proteins may contribute to proper 
retinal angiogenesis.  The expected genotypes of the offspring from crossing Notch1+/-;Notch3+/-  
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mice to Notch3+/- mice are wildtype, Notch3+/-, Notch1+/-, Notch3-/-, Notch1+/-;Notch3+/- , and 
Notch1+/-;Notch3-/-.  We analyzed these mutant mice and increased numbers for analysis by 
pooling multiple litters.  As expected, the retinal vasculature of Notch3+/- was indistinguishable 
from wildtype, thus we selected Notch3+/- mice as controls.   
To analyze the vasculature of mice mutant for Notch1 and Notch3 we isolated retinas at 
postnatal day 5 (P5) and stained them for Isolectin-B4 to visualize the vasculature and allow for 
analysis of vascular density (Figure 2, A-J).  Here we define vascular density as the percentage 
of total vascularized area with endothelial cell coverage.  As expected, Notch1+/- mice displayed 
an increase in vascular density with 45% endothelial cell coverage, as compared to 36% in 
Notch3+/- control mice (Figure 2K).  This finding was consistent with the established role of 
Notch1 in the endothelium where it functions to restrict endothelial cell sprouting59.  Interestingly, 
at P5 Notch3 nullizygous mice also displayed a statistically significant increase in vascular 
density, as compared to control.  This finding was intriguing since Notch3 expression is 
restricted to mural cells, thus the vascular phenotype observed in Notch3-/- mice was 
presumably secondary to mural cell dysfunction.  Given that both Notch1+/- mice and Notch3-/- 
mice displayed an increase in vascular density, we hypothesized that combined loss of Notch3 
with Notch1 haploinsufficiency would cause a more severe increase in vascular density.  
Analysis of the retinal vasculature at P5 of Notch1+/-;Notch3-/- mice supported this hypothesis 
with Notch1+/-;Notch3-/- mice displaying a significant increase in vascular density over Notch1+/- 
alone, 51% and 45% respectively.  Notch1+/-;Notch3+/- double heterozygous mice displayed an 
intermediate phenotype suggesting that Notch functions in a dose dependent manner to 
regulate vascular density.  As previously described, Notch3-/- mice displayed decreased 
vascular outgrowth at P5.  This phenotype was maintained in Notch1+/-;Notch3-/- mice, despite 
the fact that Notch1+/- mice have normal vascular outgrowth (Figure 2L).  
32
In addition to increased vascular density, we consistently observed abnormal vascular 
structures in retinas isolated from Notch1+/-;Notch3+/- and Notch1+/-;Notch3-/- mice.  For example, 
retinal arterioles were often seen crossing over venules (a rarity in control retinas) and unusual 
vascular loops and tangles were also observed (data not shown).  All of the mouse mutants 
analyzed (Notch1+/-, Notch3-/-, Notch1+/-;Notch3+/-, and Notch1+/-;Notch3-/-) displayed increased 
vascular branching from arterioles and venules, yet the overall structure and diameter of the 
arterioles of Notch+/-;Notch3-/-  mice appeared relatively normal.  However, venules from Notch+/-
;Notch3-/-  mice were severely enlarged and at points failed to fully differentiate from the 
neighboring capillary plexus (Figure 2,M-Q).  These findings support the hypothesis that Notch1 
and Notch3 are important regulators of angiogenesis since combined deficiency of Notch1 and 
Notch3 signaling results in increased vascular density.  Furthermore, vascular analysis suggests 
that Notch1 and Notch3 are important regulators of venular size and vessel patterning. 
 
Loss of Notch3 and partial loss of Notch1 causes retinal arteriovenous malformations 
The enlarged veins and abnormal vascular structures observed in Notch1+/-;Notch3-/- P5 
retinas suggested that vascular function may be compromised in these mutant mice.  By P12 
the retinal vascular plexus of the mouse has sufficiently matured into arterioles, venules and 
intervening capillaries to allow for the segregation of oxygenated and deoxygenated blood75,76.  
Arteriovenous malformations occur when abnormal arteries and veins make direct connections 
through either a shunt or an abnormal intervening capillary plexus10,77.  To assess the maturity 
of the vascular plexus and to analyze for the presence of AVMs in the retina, we employed a 
previously described latex perfusion assay63.  Latex perfusion is assessed after blue latex beads 
are injected into the left ventricle of the heart of a postnatal P13 pup prior to sacrifice.  In normal 
vasculature, the size of the latex beads excludes them from capillary networks and thus limits 
the latex delivery to the arterial side of circulation, which appears blue (Figure 3A).  Subsequent 
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staining for NG2 allows for the fluorescent visualization of the retinal vasculature, including the 
venules devoid of latex (Figure 3 D-F).  If AVMs and abnormal capillary plexuses are present 
the latex beads may enter venous circulation, as depicted by blue venules.  Retinas from 
Notch3-/- P13 pups consistently presented with at least one blue venule (Figure 3B).  In Notch3-/- 
mice, abnormal latex filled capillary connections can be seen feeding the venules (Figure 3H).  
This suggests that Notch3 alone is important for proper capillary structure and loss of Notch3 
can cause abnormal segregation of arterial and venular blood flow.  A dramatic AVM phenotype 
was observed in Notch1+/-;Notch3-/- P13 pups as evidenced by numerous blue venules (Figure 
3C).  Closer examination of Notch1+/-;Notch3-/- retinas following latex perfusion showed the 
presence of arteriovenous shunts and vascular tangles (Figure 3I).  AVM structures were never 
observed in control retinas (n=5) (Figure3G) or Notch1+/- mice (data not shown). Our data 
demonstrates that mural cells play an important role in regulating arteriolar, capillary and 
venular patency since Notch3 is not expressed by the endothelium.  Additional loss of Notch1 in 
a Notch3-/- background further compromises the retinal vascular plexus resulting in abundant 
and bona fide AVMs.   
 
Loss of Notch3 and partial loss of Notch1 increases retinal vascular permeability 
In the developing retinal vasculature at postnatal day 8, arterial, venous, and capillary 
structures can be appreciated.  However, at this time point the blood vessels have yet to fully 
mature and become functionally segregated78.  Vascular immaturity can be appreciated by 
performing latex bead perfusion assays on control P8 mice where, unlike at P13, blue latex is 
observed in venules and there are small micro-leaks in the capillary plexus (Figure 4A).  We 
sought to determine if Notch3-/- and Notch1+/-;Notch3-/-  mutant mice displayed delayed vascular 
maturation at P8; a time point in retinal development that precedes the observation of 
functionally defined AVMs at P13.  At P8, the severity of leaks and the number of latex-filled 
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venules was increased in Notch3-/- mice as compared to control (Figure 4B).  This phenotype 
was worsened with the addition of Notch1 haploinsufficiency.  Retinas analyzed from Notch1+/-
;Notch3-/- mice displayed severe vascular leakage and contained structures that were clearly 
vascular shunts (Figure 4C).  To further characterize the vasculature at P8 we quantified 
vascular density at this time point.  Notch1+/-;Notch3-/- mice displayed increased vascular density  
that surpassed the severity of phenotype previously observed at P5 (Figure 5).  These data 
suggest that Notch1 and Notch3 signaling regulates vessel permeability and maturation in the 
retina. 
 
Notch1 and Notch3 regulate vascular mural cell coverage in the developing retina 
Vascular leakage and endothelial hypersprouting during angiogenesis can be suggestive 
of impaired vessel maturation.  Since mural cell coverage is critical for vessel maturation and 
Notch3 is restricted to the mural cell population, we hypothesized that mural cell coverage may 
be compromised in Notch1+/-;Notch3-/-  mutant mice.  High magnification confocal stacks of 
arterioles at P8 showed that mural cell (NG2+/AMSA+) association with the endothelium was 
altered in Notch1+/-;Notch3-/-  retinas (Figure 6).  In control retinas, mural cells display normal 
cell morphology, as evidenced by an oval-shaped cell body with processes making close 
association with the underlying endothelium (Figure 6A).  In contrast, mural cells in Notch1+/-
;Notch3-/- mice do not tightly line the arterioles (Figure 6C).  Mural cell processes can be seen 
coming off of the endothelium in Notch1+/-;Notch3-/-  P8 retinas.  This data suggests that mural 
cell function may be compromised in Notch1+/-;Notch3-/-  mutant mice.    
To determine whether abnormal mural cell coverage contributes to the vascular 
phenotypes observed in Notch1+/-;Notch3-/- mutant mice we wanted to analyze the mural cell 
compartment at an earlier time point in development that precedes vessel maturation and the 
appearance of AVMs.  We believe that analysis of mural cell coverage at P5 allows for the 
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assessment of mural cell dysfunction as a causal factor for the vascular phenotypes observed at 
P8 and P13.  In the mouse retina, αSMA is a marker of a more mature and contractile VSMC 
that only lines the retinal arterioles (Chapter 1, Figure 2)15.  The remaining mural cells that line 
the venules and capillaries of the retina are NG2-positive and negative for αSMA expression.  
We consider NG2-positive mural cells localized to the capillary plexus and venules to be 
pericytes.  P5 retinas stained for NG2 to mark pericytes showed that pericytes are recruited to 
the vasculature in Notch3-/-, Notch1+/-, Notch1+/-;Notch3+/- and Notch1+/-;Notch3-/- mice (Figure 7, 
A-J).  However, when NG2 staining was normalized to percent vascular area, a marked 
decrease in pericyte coverage was observed in Notch3-/-, Notch1+/-, Notch1+/-;Notch3+/- and 
Notch1+/-;Notch3-/- mice as compared to Notch3+/- control (Figure 7K).  This suggests that both 
Notch1 and Notch3 function to regulate pericyte coverage during angiogenesis.  Pericyte 
recruitment to nascent vasculature during angiogenesis is required for vessel maturation and is 
an import cue for vascular cell quiescence.  The lack of adequate pericyte coverage in Notch1+/-
;Notch3-/- mice at P5 may contribute to the increased vascular density, increased vascular 
permeability and AVMs observed in mice mutant for Notch1 and Notch3.   
 
Notch1 and Notch3 signaling contribute to VSMC maturation 
Notch3 has been shown to be a critical regulator of VSMC maturation.  In part, reflected 
by the fact that Notch induces αSMA expression in VSMCs32,38.  AVMs in mice and humans 
have been shown to have decreased αSMA-positive mural cell coverage48,79.  Since we saw a 
more severe AVM and vascular leakage phenotype in Notch1+/-;Notch3-/- mice as compared to 
Notch3-/-  alone, we sought to determine if Notch1 is also an important regulator of mural cell 
maturation, as defined by αSMA positivity.  Again, we assessed mural cell maturation at P5 
before AVMs appear in the retina to determine whether inhibition of VSMC maturation could 
contribute to their formation.  As has previously been described, Notch3-/- mice displayed 
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decreased αSMA expression along the arteriole at P5 (Figure 8B) with normal NG2 staining 
(Figure 8L).  Notch1+/-;Notch3-/- mice displayed a greater reduction in αSMA expression, as 
compared to Notch3-/- alone (Figure 8E).  Notch1+/- and Notch1+/-;Notch3+/-  mice had normal 
αSMA signal intensity.  However, as compared to Notch3+/- control, we observed an increase in 
arteriole surface area that were devoid of αSMA staining in Notch1+/-;Notch3+/-  mice (Figure 
8D).  
These findings were supported by analysis of human brain vascular pericyte (HBVP) 
knockdown cell lines evaluated in vitro.  Protein lysates isolated from NOTCH1 knockdown and 
NOTCH3 knockdown HBVP cell lines contained less αSMA, as compared to control (Figure 8P).  
Double knockdown of NOTCH1 and NOTCH3 showed a dramatic reduction in αSMA levels as 
compared to control or either NOTCH1 or NOTCH3 knockdown alone.  However, NG2 protein 
expression remained constant in all cell lines assessed.  These findings show that both Notch1 
and Notch3 are involved in maintaining proper αSMA levels in mural cells, implicating both 
Notch receptors in mural cell maturation.   
 
Notch1 and Notch3 are critical for pericyte association with the vasculature. 
αSMA-positive VSMCs line the arterioles of the retina, yet we observed vascular 
phenotypes in Notch1+/-;Notch3-/- mice that involved arterioles, venules and capillaries. 
Inadequate VSMC maturation only partially explains the vascular phenotypes observed in 
Notch1+/-;Notch3-/-  mice as NG2-postive, αSMA-negative pericytes line all of the vascular 
structures of the retina.  Thus, we hypothesized that the retinal vascular abnormalities observed 
with decreased Notch1 and Notch3 signaling may be due to pericyte dysfunction.  Low 
magnification images of P5 control retinas stained for NG2 show that pericytes completely cover 
the endothelium with relatively uniform staining intensity (Figure 7F).  While analyzing retinas for 
pericyte coverage from Notch1+/-;Notch3-/- and Notch3-/-  mice we observed NG2-positive 
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pericytes with increased staining intensity lining the capillary plexus.  The brightly stained 
pericytes appeared to have an altered morphology and they didn’t line the endothelium as tightly 
as they do in control retinas (Figure 7F and 7H).  We showed that inhibition of Notch signaling in 
pericytes does not alter NG2 expression in vitro (Chapter 5, Figure 4).  Thus, we hypothesize 
that the aforementioned increase in NG2 staining intensity was due to an increase in cell 
surface area availability to antibody detection caused by pericyte dissociation from the 
endothelium.   
To assess for changes in pericyte/endothelial cell association we took high magnification 
confocal stacks of P5 retinas stained for CD31 to mark endothelial cells and NG2 to visualize 
pericytes.  High magnification images were taken at two locations where vascular phenotypes 
had been observed in Notch1+/-;Notch3-/- mice; the capillary plexus behind the angiogenic front 
where we saw increased vascular density and at the first branch point of the venule were we 
observed venule enlargement.  Since AVMs were not observed at P13 in the retinas of Notch1+/- 
mice we excluded this genotype in the subsequent analysis.  In the retina capillary plexus and 
venules of the Notch3+/- control mouse the cell surface of the pericytes appears smooth, the 
pericytes have uniform NG2 staining intensity, and the pericytes tightly line the endothelium 
(Figure 9, A-D).  In the Notch3-/- null retina some pericytes in the plexus displayed bright NG2 
staining and had cell processes that don’t make tight contact with the endothelium (Figure 9E).  
Pericytes lining Notch3-/- venules displayed distinctly altered cell morphology with a cell surface 
that appeared uneven and an increased number of cell processes (Figure 9G).  Pericyte 
association with the endothelium was further compromised with additional loss of Notch1 in 
Notch1+/-;Notch3-/- mice where NG2-positive pericytes can be seen coming off of the vascular 
plexus and at some points piling on top of one another (Figure 9M).  Pericyte coverage 
appeared reduced along venules of Notch1+/-;Notch3-/- retinas and again displayed altered cell 
morphology similar to that observed in Notch3-/- mice (Figure 9P).  The Notch1+/-;Notch3+/- 
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double heterozygous mice showed an intermediate phenotype with pericyte dissociation that 
surpassed that of Notch3-/- mice, but was not as severe as the phenotype observed in Notch1+/-
;Notch3-/- mice (Figure 9, I-L).  This data suggest that loss of Notch3 with a combined reduction 
of Notch1 compromises the association of pericytes with the endothelium.  The observed loss of 
proper mural cell association with the endothelium early in retinal development may contribute 
to the increased vascular density, lack of vessel maturation, and appearance of AVMs observed 
at later developmental time points in Notch1+/-;Notch3-/- mice.  
 
Notch1+/-;Notch3-/-  mice have a disorganized vascular basement membrane 
Pericytes share the vascular basement membrane with the endothelium.  Vascular 
network formation in vitro with pericytes and endothelial cells demonstrate that pericyte 
coverage of vascular networks is required for vascular basement membrane deposition6.  
Since vascular basement membrane deposition is induced when pericytes properly 
associate with endothelial cells during angiogenesis, we wanted to analyze vascular basement 
membrane deposition in the plexus and venules where we observed pericyte dissociation in 
Notch3-/-; Notch1+/-;Notch3+/-, and Notch1+/-;Notch3-/- mice.  In the retina, the main components 
of the vascular basement membrane are collagen type IV, laminin, and fibronectin.  Using high 
magnification confocal imaging we analyzed P5 retinas stained for Isolectin-B4 to visualize the 
vasculature, NG2 to mark pericytes and either collagen type IV, laminin, or fibronectin to assess 
basement membrane organization and deposition.  We observed that fibronectin is not specific 
to the vascular basement in the retina; it is strongly expressed by the underlying astrocyte 
plane.  Nonetheless, deposition of fibronectin and its organization appeared normal across 
genotypes (data not shown).  A uniform layer of collagen type IV lines the endothelium of the 
capillary plexus in Notch3+/- mice, as well as in Notch3-/- and Notch1+/-;Notch3+/- mice despite 
decreased staining intensity (Figure 10, B and C).  In the capillary plexus of Notch1+/-;Notch3-/- 
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mice, collagen type IV staining appears abnormal and severely disorganized, as it is not 
restricted to the abluminal surface of the endothelium, but instead widely dispersed across the 
plexus (Figure 10D).  Areas of intense collagen type IV staining can be seen with severe 
heterogeneity in collagen type IV staining intensity across the endothelium of the plexus of 
Notch1+/-;Notch3-/- mice (Figure 10L). Collagen type IV deposition is also severely disorganized 
in the grossly enlarged venules of Notch1+/-;Notch3-/- mice (Figure 10X).  
Localization of the vascular basement membrane component laminin was also 
dramatically altered in the plexus and venules of Notch1+/-;Notch3-/- mice.  In Notch1+/-;Notch3-/- 
mice laminin appears disorganized in the plexus where a blush of staining can be appreciated, 
which is not associated with the vasculature (Figure 11D).  In the venule, laminin fails to 
uniformly line the endothelium in Notch1+/-;Notch3-/- mice (Figure 11P).  Mild alterations of 
laminin deposition can also be observed in Notch3-/- and Notch1+/-;Notch3+/-  mice which display 
a mild blush laminin staining pattern in the plexus and venule (Figure 11, B, C, N, and O).  
These findings support a role for pericyte association with the endothelium in regulating 
basement membrane deposition.  Lack of pericyte association and abnormal basement 
membrane deposition preceded the appearance of AVMs in Notch1+/-;Notch3-/- mice.  We 
propose that pericyte dysfunction and alterations in basement membrane resulting from 
combined deficiency of Notch1 and Notch3 contributes to the AVMs that appear later in retinal 
development.  
 
Notch1+/-;Notch3-/- mice display abnormal hyaloid vasculature at P5 
During P5 retinal dissections, we observed that the blood vessels of the hyaloid vascular 
network appeared thicker and chord-like in Notch1+/-;Notch3-/- mice, in contrast to the fine 
hyaloid vasculature observed in all other genotypes assessed.  The hyaloid vascular system is a 
temporary vascular network that delivers oxygen and nutrients to the intraocular components of 
40
the developing eye61.  The hyaloid vascular network spans the vitreous space and forms a 
dense capillary plexus on the surface of the lens.  As the retina matures and becomes 
vascularized, the hyaloid progressively regresses, yet at postnatal day 5 the hyaloid vascular 
network is still relatively intact.  We isolated the hyaloid vascular network and lens from 
Notch1+/-;Notch3-/- mice and Notch3+/- mice to serve as controls.  Wholemount staining for 
Isolectin-B4 showed that the hyaloid vessels of Notch1+/-;Notch3-/- mice were thicker and denser 
when compared to control (Figure 12B).  The hyaloid vascular network of Notch1+/-;Notch3-/- 
mice also appeared to be more rudimentary than controls; they lacked the normal vascular 
hierarchy of arterioles, venules, and capillaries.  Instead the hyaloid vasculature of Notch1+/-
;Notch3-/- mice contained only larger vessels without an obvious capillary plexus found in 
controls (Figure 12B) .   
Analysis of pericyte and VSMC coverage by staining for NG2 and αSMA, respectively, 
showed dramatic differences in mural cell coverage of the hyaloid vasculature between  
Notch1+/-;Notch3-/-  and Notch3+/- mice at P5.  In the control hyaloid vascular plexus, NG2-
positive pericytes line the entire vascular network and αSMA-positive VSMCs are associated 
with the larger hyaloid arterioles that extend from the optic nerve (Figure 12C).  In Notch1+/-
;Notch3-/- mice NG2-positive mural cell coverage of the hyaloid is dramatically reduced (Figure 
12D).  Furthermore, the cell morphology of VSMCs and αSMA-negative pericytes associated 
with the hyaloid was dramatically altered in Notch1+/-;Notch3-/- mice (Figure 12F).  VSMCs in the 
Notch1+/-;Notch3-/- mice had elongated cell bodies and made contact through cellular processes 
with multiple hyaloid vessels (Figure 12H).  NG2-positive, αSMA-negative pericytes in the 
Notch1+/-;Notch3-/- display similarly abnormal cellular phenotypes (Figure 12J).  In the control, 
the hyaloid pericytes are tightly associated with the vasculature, whereas in Notch1+/-;Notch3-/- 
mice the pericytes are dissociated from the underlying endothelium (Figure 12, I and J).  Despite 
having reduced mural cell coverage, a greater number of macrophages were observed to be 
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associated with the hyaloid vasculature of Notch1+/-;Notch3-/- mice (data not shown).   Thus, 
decreased Notch1 with complete loss of Notch3 causes alterations in hyaloid and retinal 
vasculature by increasing vascular density and causing vessel enlargement.   
 
DISCUSSION 
Here we show that combined deficiency of Notch1 and Notch3 (Notch1+/-;Notch3-/-) led to 
increased vascular density, venule enlargement, increased vascular permeability, pericyte 
dissociation, and arteriovenous malformations in the developing retina.  Previous work has 
described segregated functions for vascular Notch proteins; Notch1 functions in the endothelium 
and Notch3 functions in the mural cell compartment.  In endothelial cells Notch1 signaling 
inhibits sprouting and in mural cells Notch3 functions to promote cell differentiation.  However, 
mural cells express both Notch1 and Notch3.  We showed that Notch1 and Notch3 are required 
for normal αSMA expression in pericytes in vitro and that αSMA expression is dramatically 
reduced in Notch3-/- mice with Notch1 haploinsufficiency.  We also demonstrated that combined 
loss of Notch1 and Notch3 leads to mural cell dissociation from the retinal endothelium in 
Notch1+/-;Notch3-/- mice.  These studies expand upon previous findings that pericyte coverage is 
essential for vascular maturation and quiescence and demonstrate that Notch regulates this 
process66,69,80-84.  In Notch1+/-;Notch3-/- mice, pericytes failed to properly associate with the 
endothelium of the retinal vasculature at P5.  This mural cell phenotype was associated with 
increased vascular density, enlarged venules, and abnormal vascular basement membrane 
deposition suggesting that Notch1 and Notch3 cooperate to regulate vascular maturation by 
promoting mural cell coverage during sprouting angiogenesis. 
Notch1+/-;Notch3-/- mice presented with numerous retinal AVMs characterized by 
vascular tangles, abnormal capillaries and arteriovenous shunts that recapitulated human 
AVMs.  Retinal AVMs are rare, congenital vascular anomalies that, like brain AVMs, are 
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characterized by dilated, tortuous high pressure vascular tangles and arteriovenous shunts85.   
Since the vasculature of the retina-blood barrier shares many characteristics with the blood- 
brain barrier, the ease of vascular analysis of the retina makes retinal AVMs an attractive model 
for understanding the mechanisms that govern the development of cerebral vascular 
malformations.  Previous studies implicate Notch activation in brain AVMs42,44,45.  Notch1 is often 
upregulated in the endothelium and VSMCs of human brain AVMs44.  Endothelial Notch4 
activation during mouse brain development induces the formation of cerebral high-flow 
arteriovenous shunts45.  Furthermore, normalization of Notch4 expression in AVMs induces 
regression through a decrease in vessel size and reemergence of a normal capillary plexus86.  
Our work shows that loss of Notch expression can also cause AVMs, as demonstrated by the 
retinal AVMs observed in Notch1+/-;Notch3-/- mice.   Current models for Notch in AVMs focus on 
Notch in the endothelium.  Murphy et al. provide an elegant model that centers on arteriovenous 
specification and with evidence supporting a model that activated Notch causes venule 
arterialization.  In addition, they show that when Notch expression is normalized, endothelial 
cells regain their venular identity and AVM regression ensues86.  In our mouse model, Notch 
expression is lost in both endothelial cells and mural cells, thereby expanding the functional role 
of Notch in vascular abnormalities.  Thus, we conclude that loss of Notch in both cell types 
contributes to AVM formation.  
In Notch1+/-;Notch3-/- mice, pericyte dissociation from the endothelium was observed 
prior to the emergence of retinal AVMs.  We suspect that the dramatic loss of pericyte 
association with the endothelium in Notch1+/-;Notch3-/- mice contributes to the vascular 
abnormalities observed in these mutant mice.  The mechanism underlying pericyte dissociation 
in Notch1+/-;Notch3-/- mice remains to be determined.  Pericytes share a basement membrane 
with the endothelium, and their recruitment to nascent blood vessels has been shown to be 
critical for proper vascular basement membrane deposition6,15.  The vascular basement 
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membrane has also been shown to limit endothelial cell sprouting through regulation of 
endothelial Notch signaling87,88.  We observed that Notch1+/-;Notch3-/- mice had an altered 
vascular basement membrane characterized by reduced laminin expression and enhanced 
fibronectin expression.  Furthermore, Notch1+/-;Notch3-/- mice displayed severe disorganization 
of both collagen type IV and laminin in the capillary plexus and venules.  Our model posits that 
the retinal vasculature of Notch1+/-;Notch3-/- mice fails to become quiescent due to loss of proper 
pericyte coverage and altered basement membrane deposition.  Lack of vessel quiescence in 
Notch1+/-;Notch3-/- mice presents as increased vascular density, venule enlargement and 
contributes to the observed AVMs in Notch1+/-;Notch3-/- mice.  It is also possible that pericytes in 
Notch1+/-;Notch3-/- mice could have an impaired ability to interact with the basement membrane.  
Integrins bind the basement membrane and are critical regulators of angiogenesis89.  Notch 
signaling in retinal αSMA-positive VSMCs regulates integrin αvβ3 expression allowing for 
adhesion of VSMCs to von willebrand factor (VWF) in the basement membrane90.  Vascular 
integrin expression may be altered in Notch1+/-;Notch3-/- mice, which requires further 
investigation.  
Notch1+/-;Notch3-/- mice also displayed abnormal hyaloid vasculature.  This phenotype 
included increased vessel content, vessel thickening and abnormal mural cell coverage at 
postnatal day 5.  These observations support a role for Notch1 and Notch3 in pericyte function 
in multiple vascular beds.  However, whether Notch functions in hyaloid mural cells to regulate 
the development or regression of the hyaloid vascular plexus remains to be determined.   
The severity of the vascular phenotypes displayed by Notch1+/-;Notch3-/- mice highlights 
an important role for Notch in pericyte function by regulating their association with the 
endothelium.  We demonstrate that Notch regulated pericyte association is critical for proper 
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Figure 1. Notch1 and Notch3 are expressed by pericytes. The vascular plexus of P5 
retinas isolated from Transgenic Notch Reporter (TNR) mice stained for GFP (green) to visual-
ize Notch activation in endothelial cells (red) and pericytes (blue) (A). PCR amplification using 
primers specific for NOTCH1 and NOTCH3 of cDNA isolated from HUVEC or HBVP. β-ACTIN 



















































































A B C D E
F G H I J
N3-/-N3+/- N1+/-;N3-/-N1+/- N1+/-;N3+/-
N3-/-N3+/- N1+/-;N3-/-N1+/- N1+/-;N3+/-
Figure 2. Notch1 and Notch3 limit vessel density in the retina at P5. Wholemount retinas 
isolated from P5 mice stained for Isolectin-B4 to visualize the vasculature (A-J, M-Q). Tiled 
confocal stacks show the entire primary plexus and vascular outgrowth (A-E). Confocal stacks 
of individual retinal leaflets allow for greater detail (F-J). Quantification of vessel density as 
measured by percent of IsolectinB4 staining within the total vascularized area (K). Quantifica-
tion of vascular outgrowth as measured by the average distance (μm) between the optic nerve 
and furthest vascular point of each leaflet (L). Confocal stacks of venules taken at the first 
branch point from the optic nerve show enlargement of Notch1+/-;Notch3-/-  venules, as com-
pared to control (M-Q). Red lines mark venule diameter. Scale bars; 500 μm (A-E), 200 μm 
(F-J), 50 μm (M-Q).  Error bars represent SD of the mean. n≥3, with 8 leaflets/mouse,*p<0.01, 









































Figure 3. Latex bead perfusion shows arteriovenous malformations in Notch1+/-;Notch3-/- 
mouse retinas. Bright field images of wholemount retinas isolated from P13 mice following 
blue latex bead perfusion (A-C). Corresponding fluorescent images of the same whole mount 
retinas stained for NG2 to visualize the vasculature (D-F), venules marked by “V”. Higher 
magnification images (G-H) show blue venules (asterisks), arteriovenous shunts (arrow) and 























Figure 4. Notch1+/-;Notch3-/- mice display decreased retinal vascular maturity at P8. 
Bright field images (A-C) and corresponding fluorescent Isolectin-B4 staining (D-F) of retinal 
leaflets of P8 mice following blue latex bead perfusion. Bright field images show blue venules 
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Figure 5. Notch1 and Notch3 limit vessel density in the retina at P8. Wholemount retinas 
isolated from P8 Notch1/Notch3 mutant mice stained for Isolectin-B4 to visualize the vascula-
ture (A-J). Low magnification images show a severe increase in vessel density in the vascular 
plexus of Notch1+/-;Notch3-/- mice (A-E). High magnification images were used to quantify 
vascular density (F-J). Quantification of percent area coverage quantified from high magnifica-
tion confocal stacks taken at the vascular plexus behind the arteriovenous vascular front (K). 
n≥3, 4 images taken per retina. **p< 5x10-4, ***p<5x10-5. Error bars represent SD of the mean.  
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Figure 6. Notch1+/-;Notch3-/-  P8 mice display loss of arteriolar mural cell association
Mural cell association is assessed from high magnification confocal stacks taken through the 
center of the arteriole at the first branch point from the optic nerve. Endothelial cells are 
stained with CD31 (green) and mural cells are stained for αSMA (red) and NG2 (magenta). 
Dissociated mural cells are marked with white arrowheads. Scale bars; 25 μm. 
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Figure 7. Notch1+/-;Notch3-/- P5 mice display reduced pericyte coverage. Confocal stacks 
of leaflets of P5 retinal wholemounts stained for CD31 (red) and NG2 (green) (A-J). NG2 alone 
shows that pericytes recruitment occurs in all mutant mice analyzed. Quantification of NG2 
staining normalized to vascular area shows that Notch3-/-, Notch1+/-, Notch1+/-;Notch3+/- and 
Notch1+/-;Notch3-/-  mice have decrease vascular pericyte coverage as compared to Notch3+/- 
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Figure 8. Notch1 and Notch3 are required for mural cell αSMA expression. High magnifi-
cation confocal stacks taken of arterioles at the first branch point distal to the optic nerve. 
Wholemount retinas were stained for CD31 (blue) to visualize the endothelium, NG2 (green), 
and αSMA (red) to visualize more mature VSMCs (A-O). Notch1+/-;Notch3-/-  mice show a 
significant reduction in αSMA expression.  Western blot on protein lysates isolated from HBVP 
cell lines expressing scrambled shRNA (control), NOTCH1-shRNA, NOTCH3-shRNA, or both 
NOTCH1- and NOTCH3-shRNA (P). The blot was probed for NG2, αSMA, and vinculin as a 
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Figure 9. Pericyte association with the endothelium is compromised in the retina of 
Notch1+/-;Notch3-/- P5 mice. High magnification confocal stacks taken at the vascular plexus 
behind the arterial/venous vascular front (A-B, E-F, I-J, M-N) and of the venule at the first 
branch point form the optic nerve (C-D, G-H, K-L, O-P). Images were taken of wholemount 
retinas fluorescently stained fro CD31 (red) to visualize the endothelium and NG2 (green) to 











































Figure 10. Notch1+/-;Notch3-/- mice display altered collagen type IV deposition. High 
magnification confocal stacks of P5 retinas stained for isolectin-B4 (red), NG2 (green), and 
collagen type IV (colIV) (blue). Images were taken at the capillary plexus (A-L) and of the 

















































Figure 11. Notch1+/-;Notch3-/- mice display altered laminin deposition. High magnification 
confocal stacks of P5 retinas stained for isolectin-B4 (red), NG2 (green), and laminin (blue).  
Images were taken at the capillary plexus (A-L) and of the venule at the first branch point from 










































Figure 12. Assessment of the hyaloid vasculature of Notch1+/-;Notch3-/- mice at P5. The 
hyaloid vasculature and lens was wholemount stained for isolectin-B4 (blue), NG2 (green) and 
αSMA (red). Low magnification confocal stacks show an altered hyaloid vascular plexus in 
Notch1+/-;Notch3-/- mice (A-D). Zoomed area of white boxes allows for analysis of mural cell 




























Physiological angiogenesis is essential during development to establish the circulatory 
system.  In adulthood, angiogenesis is mainly restricted to diseased states characterized by 
inflammation, such as wound healing and tumor vascularization.  In adult mammals, the female 
reproductive tract is a unique site of physiological angiogenesis.  Angiogenesis in the ovary and 
uterus are required for maintenance of the non-pregnant estrous/menstrual cycle and for 
establishment and maintenance of pregnancy.  The ovary supports the reproductive lifespan of 
an organism through cyclic production of follicles, follicular maturation, ovulation of oocytes, 
development of the corpus luteum (CL) and luteal regression, in the non-pregnant state (Figure 
1).  After ovulation of an oocyte from the dominant follicle, the CL develops.  Ovulation induces 
follicular granulosa cells to proliferate and then terminally differentiate into hormone producing 
luteal cells91.  Steroid hormone production, such as estradiol and progesterone by luteal cells is 
critical for pregnancy maintenance and requires a functional capillary plexus for hormonal 
delivery to distant sites.  Thus, angiogenesis in the corpus luteum must occur efficiently and 
effectively to ensure its function as an endocrine organ.   
Initiation of luteal angiogenesis occurs immediately following ovulation when the 
basement membrane surrounding the ovulated follicle is degraded allowing for theca vessels to 
invade the avascular granulosum92,93.  Proliferation and migration of the theca endothelial cells 
is dependent on VEGF-A, which is primarily secreted by the follicular granulosa cells94,95.  
VEGF-A has been shown to be required for luteal angiogenesis, as VEGF blockade inhibits 
angiogenesis in the corpus luteum and impairs luteal function96-98.  VEGFR-2 has been shown to 
be an essential receptor for VEGF-A in endothelial cells during luteal angiogenesis99,100.  
In addition to the VEGF pathway, pericytes have also been shown to regulate luteal 
angiogenesis.  Unlike developmental angiogenesis, where pericyte recruitment is typically 
secondary to that of endothelial cell recruitment, in some animal models pericytes are the first 
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vascular cells to invade the ovulated follicle101.  Analysis of sheep ovaries suggested that luteal 
pericytes promote vascular recruitment to the CL through secretion of VEGF-A101.  Thus, it has 
been proposed that pericytes may function as vascular guides within the developing corpus 
luteum92.  Pericytes also fulfill their traditional vascular role in the CL by providing maturation 
cues and support to nascent capillary vessels102.  The importance of vascular pericytes in luteal 
angiogenesis has been shown previously by inhibiting their recruitment to the CL in mice10.  
Blockade of pericyte recruitment through expression of soluble PDGFRβ ectodomain caused 
severe luteal hemorrhaging, as well as decreased luteal vascularization.  This work 
demonstrates that pericytes have a dual function in luteal angiogenesis by promoting both 
endothelial recruitment and vessel stability.  
The Notch pathway is a critical regulator of both endothelial function and 
pericyte/endothelial interactions during angiogenesis.  Previous work by our group 
demonstrated that Notch1 and Notch4 are expressed by luteal and theca endothelial cells, 
whereas Notch3 is expressed by theca mural cells103.  In addition, luteal endothelial cells and 
mural cells express the Notch ligand, Jagged1.  Analysis of mouse models mutant for Jagged1 
showed that endothelial Jagged1 activates Notch signaling in mural cells to promote mural cell 
maturation and coverage of the vasculature36,37,90.  In the developing retina, specific deletion of 
endothelial Jagged1 caused decreased vascular density and decreased αSMA expression by 
the mural cell compartment37.  Unpublished data from our group showed that therapeutic 
inhibition of Jagged-specific Notch activation resulted in decreased tumor vessel density and 
loss of pericyte/endothelial cell association in the tumor vasculature (Kangsamaksin T., et al., 
unpublished data).  Thus, we hypothesized that inhibition of Jagged-specific Notch signaling 
would inhibit luteal angiogenesis by altering pericyte function.  Using tools to specifically inhibit 
Notch activation by Jagged we demonstrate that Jagged-specific Notch signaling is required for 
pericyte recruitment to the CL following controlled hormonal stimulation of ovulation in the 
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mouse.  We also show that Jagged/Notch signaling is critical for luteal vessel stability under 
more intense angiogenic conditions induced by ovarian hyperstimulation.  Inhibition of Jagged-
specific activation of Notch caused luteal hemorrhaging and loss of vascular pericyte 
association following ovarian hyperstimulation.  
 
RESULTS 
Characterization of the mural cell population in the corpus luteum  
To analyze angiogenesis in the corpus luteum, we employed a model of hormonal 
induction of ovulation.  Ovulation was induced in sexually immature female C57/Bl6 mice by 
intraperitoneal injections of 5 i.u. of pregnant mare serum gonadotropin (PMSG) to induce 
folliculogenesis, followed by 5 i.u. of human chorionic gonadotropin (hCG) two days later, to 
induce ovulation and luteinization.  Ovaries were collected two days after hCG injection (day 4) 
and used to assess luteal angiogenesis.  
 We defined the mural cell population of the ovary following hormonal induction of 
ovulation through assessment of mural cell marker expression (NG2, PDGFRβ, desmin, and 
αSMA) in ovaries isolated from sexually immature females induced to ovulate with PMSG and 
hCG.  In the mouse retina, the pericytes that line the capillaries are positive for NG2, desmin, 
and PDGFRβ, but do not express the more mature VSMC marker, αSMA (Chapter 1, Figure 2).  
We observed a similar pattern of expression in the ovary where the mural cells lining the luteal 
capillaries are positive for NG2, desmin, and PDGFRβ, and negative for αSMA.  Interestingly, 
we also observed specific staining patterns for NG2, desmin, and PDGFRβ within the CL.  NG2 
strongly stains the mural cells in the CL, but the staining intensity for NG2 is weak in the theca 
(Figure 2A).  PDGFRβ was strongly expressed by luteal and theca mural cells, which was 
expected because it functions in pericytes and VSMCs (Figure 2B).  The mural cells in the theca 
layer express higher levels of desmin than the CL mural cells suggesting desmin may mark a 
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more mature mural cell population (Figure 2C).  αSMA expression was restricted to the mural 
cell population of the theca layer (Figure 2D).  The observed expression pattern of mural cell 
markers in the ovary demonstrated that CL vessels are lined by pericytes, whereas the theca 
vessels are lined by both pericytes and VSMCs.  Differences observed in mural cell populations 
of the CL is likely due to different requirements for mural cell function in the CL versus the 
ovarian theca.  The theca layer contains larger and more established blood vessels that require 
support from more mature and contractile αSMA-positive VSMCs.  The transient capillary plexus 
of the CL may instead require a mural cell population that is more versatile and active in 
angiogenesis, such as the pericyte.  
  
Luteal pericytes express Notch1 and Jagged1 
To determine if Notch signaling could contribute to pericyte function in the CL we 
analyzed Notch receptor and ligand expression in luteal pericytes.  Previous work by our group 
showed that Notch1 is expressed by a subset of luteal and theca endothelial cells, as well as a 
subset of αSMA-positive mural cells in the theca layer103.  Jagged1 displayed a similar 
localization.  In situ hybridization on ovarian sections showed that Notch2, Notch3, and Jagged2 
are expressed by granulosa cells of the developing follicle and that Jagged2 is not expressed by 
the ovarian vasculature104.  Since we demonstrated that NG2 is a specific and consistent marker 
of luteal pericytes we co-stained ovary sections for NG2 and either Notch1, Notch3 or Jagged1 
to determine the Notch expression profile of luteal pericytes.  Co-staining for NG2 and Notch1 
showed that a small subset of pericytes express Notch1 in the CL (Figure 3A).  Co-staining for 
NG2 and Jagged1 showed that luteal pericytes express high levels of the Notch ligand Jagged1 
(Figure 3B).  Notch3 is not expressed by luteal pericytes, instead Notch3 expression is 
restricted to the mural cells of the theca layer (Figure 3C).  Thus, luteal pericytes express 
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Notch1 and Jagged1.  This data suggests that luteal angiogenesis could be compromised 
pharmacologically by specifically targeting the Jagged activation of Notch signaling.   
 
N110-24 decoy, a Jagged inhibitor, does not affect ovulation 
Given that luteal pericytes express Notch1 and Jagged1, we hypothesized that 
disrupting Jagged/Notch interactions could alter pericyte coverage and function of the CL 
capillary plexus.  To inhibit Jagged-specific activation of Notch we have employed a Notch 
decoy construct developed in our lab that contains EGF-like repeats 10-24 of the human 
NOTCH1 extracellular domain, deemed N110-24 decoy (Figure 4).  We refer to this construct as a 
decoy because the Notch extracellular domain does not have signaling capability, but functions 
to bind ligand and thus inhibits Notch signaling.  N110-24 decoy has been shown to specifically 
block Jagged ligands (both Jagged1 and Jagged2) and bind to Jagged1.  N110-24 decoy is thus a 
Jagged-specific inhibitor of Notch signaling, whereas full-length human Notch1 extracellular 
domain (EGF-like repeats 1-36) binds both delta-like ligands and Jagged ligands to inhibit Notch 
signaling (Kangsamaksin, T., et al., unpublished data)105.  During pathological angiogenesis, we 
previously showed that N110-24 decoy disrupts pericyte/endothelial cell interactions in tumor 
vasculature and causes decreased vascular density, therefore we were interested in analyzing 
the affects of N110-24 decoy on physiological angiogenesis in the CL (Kangsamaksin, T., et al., 
unpublished data).   
To analyze the effects of N110-24 decoy on luteal angiogenesis, we induced ovulation in 
pre-pubertal female mice that had been infected with an adenovirus expressing human Fc 
(control group) or an adenovirus expressing N110-24 decoy (experimental group).  These human 
adenovirus vectors infect the murine liver causing hepatocytes to produce and secrete protein 
into systemic circulation (data not shown).  Thus, adenoviral vectors are used to express 
secreted proteins of interest to allow for their systemic delivery into the bloodstream and 
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evaluation as therapeutic entities in the mouse.  In a pilot study, we analyzed serum Fc levels 
following injection of adenovirus expressing Fc during hormonal induction of ovulation.  Serum 
Fc can be detected the day immediately following adenovirus injection with increasing levels 
observed up until the time of ovary collection at day 4 (Figure 5A).  To allow folliculogenesis to 
proceed normally while still affecting luteinization we injected female mice with adenovirus on 
the day between PMSG and hCG treatment (Figure 5B). 
In experiments to assess N110-24 decoy function, mice injected with adenovirus 
expressing N110-24 decoy or human Fc expressed high serum levels of their respective decoys at 
time of ovary collection (Figure 5C).  Ovaries isolated from N110-24 decoy treated mice with 
controlled hormonal stimulation were smaller by weight, as compared to control (Figure 5E).  
H&E staining of sections of ovaries showed that copora lutea were present in N110-24 decoy 
treated ovaries (Figure 5D).  Quantification of CL number showed no significant difference 
between groups, suggesting that N110-24 decoy does not affect ovulation or CL formation (Figure 
5, F and G).     
 
N110-24 decoy inhibits luteal angiogenesis 
Angiogenesis is required for luteinization and maintenance of pregnancy.  Previous 
studies have shown that inhibiting luteal angiogenesis by blocking VEGF signaling results in 
decreased ovarian weight99.  We hypothesized that the decreased ovarian weight observed in 
the N110-24 decoy treatment group may be caused by reduced luteal angiogenesis.  To analyze 
CL vessel content we stained ovaries for the endothelial cell marker CD31.  As hypothesized, 
ovaries isolated from mice treated with N110-24 decoy displayed decreased CL endothelial 
content, as compared to controls (Figure 6A).  The corpora lutea of N110-24 decoy treated mice 
displayed a 30% reduction in vessel density (Figure 6B).  This data suggests that Notch 
activation through Jagged is pro-angiogenic in the CL  
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 Pericytes have been shown to promote angiogenesis in the ovarian corpus luteum10.  
Furthermore, data from our lab showed that Jagged-specific activation of Notch signaling 
regulates pericyte/endothelial cell interactions.  To determine whether N110-24 decoy affects 
pericyte recruitment to the CL vasculature we stained ovarian sections for the pericyte marker 
NG2.  We observed that there was a significant reduction in NG2 positive cells in the corpora 
lutea of Notch110-24 decoy treated mice, as compared to control (Figure 7A).  This difference was 
statistically significant; the N110-24 decoy group showed a 30% reduction in pericyte cell content 
in the CL compared to control (Figure 7B).  However, a significant difference was not observed 
between the two groups when we assessed pericyte coverage per vessel of the CL capillary 
plexus by normalizing NG2 staining to CD31 (Figure 7C).  Thus, N110-24 decoy inhibited CL 
pericyte content to the same extent as it inhibits endothelial content following controlled ovarian 
stimulation. 
 
N110-24 decoy causes luteal hemorrhaging in hyperstimulated ovaries  
Our experiments demonstrated that inhibition of Jagged-specific Notch activation causes 
decreased luteal angiogenesis in a model of ovulation induction while pericyte coverage of the 
luteal vasculature is unaffected.  Pericyte coverage is essential to maintain vessel stability and 
reduce vascular permeability.  In human diseases, lack of adequate pericyte coverage can lead 
to aneurysm and hemorrhaging when vascular function is stressed.  Gonadotropin induced 
hyperstimulation of ovaries induces a greater number of follicles to ovulate and thus an increase 
in CL number, as compared to induction of ovulation with controlled ovarian stimulation.  In 
addition, superovulation is accompanied by a more robust angiogenic response and more active 
endothelium as defined by increased sprouting.  We sought to determine whether Notch 
signaling could affect pericyte function in the CL of hormonally hyperstimulated ovaries with 
increased angiogenesis, compared to controlled stimulation.  To induce superovulation we used 
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the same experimental design as previously described, but increased the dose of gonadotropins 
to 20 i.u PMSG and 20 i.u. hCG (Figure 8A).  Adenovirus infection with human Fc or N110-24 
decoy resulted in high serum expression levels by experimental day 4 (Figure 8B).   
 Ovarian hyperstimulation with N110-24 decoy treatment caused severe hemorrhaging in 
the ovary.  Hyperstimulated ovaries isolated from mice treated with N110-24 decoy displayed 
numerous blood-filled corpuscles, which were rarely observed in control (Figure 8C).  We also 
observed an increase in ovarian weight in the N110-24 decoy treated group, as compared to 
controls (Figure 8D).  Closer analysis of H&E stained sections showed that ovaries from N110-24 
decoy treated mice contained multiple blood-filled corpora lutea (Figure 8E).  On average, the 
N110-24 decoy treated group had significantly more hemorrhaging corpora lutea per ovary, as 
compared to controls treated with human Fc (Figure 8F).  Yet, no significant difference was 
observed in normal CL content between the two groups.  This was surprising, as we expected to 
see a reduction in normal CL number in the N110-24 decoy group due to hemorrhaging.  This data 
instead suggests that the N110-24 decoy group may have a higher number of ovulated follicles, as 
compared to control.  
 
Inhibition of Jagged-specific Notch activation causes vessel dilation without affecting 
luteal pericyte recruitment.  
The luteal hemorrhaging observed with N110-24 decoy treatment suggested that N110-24 
decoy caused luteal vascular instability in hyperstimulated ovaries.  N110-24 decoy did not alter 
vascular density under conditions of superovulation (Figure 9I).  However, when analyzing the 
vascular plexus of non-hemorrhaged corpora lutea we noticed that the vessels in the N110-24 
decoy treated ovaries appeared enlarged and dilated, as compared to ovaries treated with 
human Fc (Figure 9, A and B).  Vessel dilation is a common phenotype associated with 
vasculature that lacks adequate mural cell coverage, as displayed by mice with impaired 
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endothelial Jagged1 expression36.  Thus, we hypothesized that pericyte coverage may be 
reduced in the CL when Jagged-specific Notch signaling was inhibited.  We stained 
superovulated ovaries for NG2 to analyze CL pericyte content, but did not see a reduction in 
pericyte recruitment to the CL in the N110-24 decoy treated group (Figure 9J).  We also stained 
hyperstimulated ovaries for αSMA to analyze theca VSMC content.  We saw that N110-24 decoy 
treatment caused decreased αSMA expression in the VSMC of the ovarian theca (Figure 10).  
Decreased αSMA staining intensity suggests that N110-24 decoy has an inhibitory affect on mural 
cell maturation.  Inhibition of VSMC maturation could cause altered vascular tone in the ovary 
and may contribute to the ovarian hemorrhaging phenotype observed in the N110-24 decoy 
treatment group.  However, as shown in Chapter 4, Figure 2, pericytes in the CL do not express 
αSMA, so lack of VSMC maturation may contribute to theca vessel dysfunction, but cannot 
explain the luteal hemorrhaging and luteal vessel dilation caused by N110-24 decoy treatment.  
 
Inhibition of Jagged-specific Notch activation disrupts pericyte association with luteal 
blood vessels  
Since inhibition of Jagged-specific activation of Notch does not affect luteal pericyte 
recruitment, we hypothesized that N110-24 decoy may inhibit pericyte association with luteal 
vessels to cause the observed vascular phenotypes.  When analyzing luteal pericyte content of 
non-hemorrhaged corpora lutea by staining for NG2.  We observed that luteal pericytes in  
N110-24 decoy hyperstimulated ovaries had a more intense NG2 signal than those in the control 
group.  In vitro data from our lab showed that Notch does not regulate NG2 protein levels in 
cultured pericytes (Chapter 5, Figure 4).  Instead, bright NG2 staining suggested that pericytes 
could be dissociating from the vasculature, as we have observed similar changes in NG2 
staining intensity in the retina of mouse mutants that display altered pericyte/endothelial cell 
association.  Since NG2 is a cell surface marker, we believe that brighter NG2 staining is due to 
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an increase in cell surface availability to the antibody when pericytes detach from the 
endothelium.  To more thoroughly analyze pericyte/endothelial cell association we took high 
magnification confocal stacks of copora lutea stained for CD31 (endothelium) and NG2 
(pericytes).  In the control CL we observed pericytes tightly lining the capillary vessels (Figure 
11C).  However, in the N110-24 decoy group luteal pericyte morphology was dramatically altered 
where pericytes appeared to be coming up and off of the endothelium with numerous cellular 
processes that failed to make contact with the endothelium (Figure 11D).   
A similar phenotype of pericyte dissociation and vessel dilation was observed in the 
remaining capillary plexus of hemorrhaging corpora lutea of N110-24 decoy treated mice.  
Analysis of the peripheral vasculature of hemorrhaging corpora lutea showed severe vessel 
dilation in the N110-24 decoy group, as denoted by arrows where large vessel lumens lined by 
CD31-positive endothelial cells can be observed (Figure 12D).  Capillary vessel wall structure 
also appears to be altered in the capillary plexus of hemorrhaging corpora lutea of the N110-24 
decoy group where the endothelial lining of the capillary lumen is discontinuous and at points 
NG2-positive pericytes can be seen lining the capillary lumen (asterisk).  This phenotype was 
not observed in the rare hemorrhaging CLs of the control super-ovulated ovaries (Figure 12C).  
This data suggests that the CL hemorrhaging observed in the N110-24 decoy treated group may 
be due to altered pericyte association leading to vessel abnormalities and thus vascular rupture 
and hemorrhaging.  
 
DISCUSSION 
 Luteal angiogenesis is a tightly regulated process that is critical for mammalian 
reproduction.  Following ovulation luteal cells proliferate and differentiate to secrete steroid 
hormones.  The capillary plexus of the corpus luteum ensures systemic delivery of luteal 
hormones without which successful implantation cannot occur and pregnancy is not maintained.  
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To ensure its function, the corpus luteum must have adequate vessel perfusion, which is 
regulated by angiogenic sprouting, remodeling, and vessel stabilization by pericyte coverage.  
By employing N110-24 decoy we showed that Jagged-specific activation of Notch regulates luteal 
angiogenesis by promoting vessel density and pericyte association with luteal endothelium.  
Specifically, we showed that following controlled ovarian stimulation, which models physiological 
angiogenesis, treatment with N110-24 decoy inhibits luteal angiogenesis.  Furthermore, in a 
setting more similar to pathological angiogenesis, N110-24 decoy caused luteal hemorrhaging and 
inhibited luteal vascular pericyte coverage following ovarian hyperstimulation.   
Through endothelial cell autonomous signaling, Jagged1 promotes sprouting 
angiogenesis by muting Dll4-activation of Notch signaling37.  In addition, Jagged1 expressed by 
endothelial cells and mural cells activates Notch signaling in mural cells to regulate their 
maturation and coverage of the vasculature32,36,106.  Our lab has previously analyzed ligand-
specific Notch decoys in tumor angiogenesis.  This work demonstrated that Jagged ligands act 
as positive regulators of angiogenesis in the tumor environment.  Inhibition of Jagged-specific 
activation of Notch using N110-24 decoy inhibits tumor vascular density (Kangsamaksin, T., et al., 
unpublished data).  We also observed that N110-24 decoy treatment impairs pericyte association 
with the tumor vasculature.  Here we show that N110-24 decoy also inhibits physiological 
angiogenesis in the adult mouse corpus luteum following controlled ovarian stimulation.  This 
data demonstrates that Jagged ligands function to promote angiogenesis in a variety of vascular 
beds.  N110-24 decoy inhibits Jagged1 and Jagged2 activation of Notch (Kangsamaksin, T., et al., 
unpublished data).  We believe that N110-24 decoy effectively inhibits luteal angiogenesis by 
preventing Jagged1 from signaling to Notch within the endothelium.  In addition, we believe that 
N110-24 decoy inhibits Jagged-induced Notch activation in mural cells to prevent proper pericyte 
function during angiogenesis.  During luteal angiogenesis, pericytes are often observed ahead 
of the vascular front.  Based on their location, pericytes may be a source of angiogenic factors, 
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such as VEGF-A and inhibition of Notch signaling by N110-24 decoy may impair this process.  
Since N110-24 decoy is secreted systemically it inhibits ligand presentation by every Jagged-
expressing cell.  Thus, we cannot determine whether the observed phenotypes result from 
inhibition of Jagged induced Notch activation by endothelial cells, mural cells, or non-vascular 
cell types in the CL.  Granulosa cells of the CL have been shown to express Notch2, Notch3, 
and Jagged2 and effects of N110-24 decoy treatment on granulosa cell function was not 
assessed.  To determine mechanistically why inhibition of Jagged-specific activation of Notch 
causes reduced angiogenesis, mouse models with tissue specific manipulation of Jagged 
should be employed.   
Our data provides a new role for Notch signaling in female reproduction.  Inhibition of 
luteal angiogenesis by blocking Jagged-specific activation of Notch could prevent uterine 
implantation of fertilized oocytes, and thus pregnancy.  Analysis of the effects of N110-24 decoy 
on female reproduction was beyond the scope of this chapter.  However, future experiments 
should include analysis of circulating luteal hormone levels following N110-24 decoy treatment.  
We predict that reduced luteal angiogenesis would correlate with reduced levels of circulating 
progesterone in mice treated with N110-24 decoy.  In humans, implantation occurs 7 to 9 days 
after ovulation and requires a functional corpus luteum.  If the anti-angiogenic effects of N110-24 
decoy cause reduced luteal function then N110-24 decoy treatment may prevent successful 
implantation, and thus inhibit pregnancy.  Use of N110-24 decoy as an emergency contraceptive 
could expand its therapeutic potential.  Future experiments should investigate the effects of 
N110-24 decoy during implantation and pregnancy. Furthermore, we strongly believe that the 
effects of N110-24 decoy  on female fertility must be assessed prior to its use in clinic as a cancer 
therapeutic.    
In the hyperstimulated ovary we showed that Jagged activation of Notch signaling is 
required for pericytes to properly associate with luteal endothelial cells.  It is well established 
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that endothelial Jagged1 is required during embryonic development to promote VSMC coverage 
of large vessels.  Mice mutant for endothelial Jagged1 display vessel dilation presumably due to 
impaired arterial VSMC maturation resulting from reduced Notch signaling28,36.  The role of 
Notch signaling in pericyte/endothelial cell interactions is less clear.  Postnatal analysis of mice 
mutant for endothelial Jagged1 demonstrated that pericyte recruitment occurs normally in this 
mouse model37.  Here we demonstrate that Jagged-specific activation of Notch does not alter 
the quantity of pericyte coverage of luteal vessels, but instead affects the ability of pericytes to 
properly associate with the endothelium during luteal angiogenesis.  
We observed severe luteal hemorrhaging and pericyte dysfunction in hyperstimulated 
ovaries with N110-24 decoy treatment.  Ovarian hemorrhaging and pericyte dissociation was not 
observed with N110-24 decoy treatment following controlled ovarian stimulation.  We believe that 
hyperstimulation of ovulation using high doses of gonadotropins models pathological 
angiogenesis.  The increased number of ovulated follicles and the robust angiogenic response 
following superovulation suggests that the luteal endothelium is hyperactive in hyperstimulated 
ovaries.  In the clinic, ovarian hyperstimulation is induced by gonadotropin administration during 
in vitro fertilization therapy to increase ovulation.  Ovarian hyperstimulation syndrome (OHSS) 
occurs for unknown reasons in a subset of patients undergoing in vitro fertilization.  The luteal 
vasculature of patients with OHSS is characterized by vessel leakiness due to increased levels 
of VEGF-A107.  The relative luteal VEGF-A levels of mice hyperstimulated with high doses of 
gonadotropins have not been assessed.  However, we would predict that similar to human, in 
the mouse, ovarian hyperstimulation causes increased VEGF-A levels and thus a hyperactive 
luteal endothelium.  Only under conditions of hyperstimulation did we observe overt pericyte 
dissociation and vascular dysfunction.  In the retina and in vitro we have shown that Notch 
signaling regulates pericyte function.  We believe that during physiological angiogenesis, as 
occurs in the CL following controlled ovarian stimulation, compensation for altered pericyte 
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function can achieve a functional, despite sparser, luteal capillary network.  However, when 
activation of the endothelium is enhanced for example via hormonal ovarian hyperstimulation 
the effects of altered pericyte function cannot be overcome and results in a dysfunctional luteal 
capillary plexus.  We believe that this is why we observed luteal hemorrhaging only in 
hyperstimulated ovaries treated with Notch110-24 decoy, and not under conditions of controlled 
ovarian stimulation.    
It has previously been reported that inhibition of pericyte recruitment to the CL causes 
luteal hemorrhaging and reduced vascular density10. Kuhnert et al. demonstrated that luteal 
pericytes function to regulate endothelial sprouting and vessel stability in the CL.  Our data 
expands upon this work by showing that Jagged-induced Notch signaling is critical for pericyte 
function during luteal angiogenesis.  The exact mechanism by which Notch signaling regulates 
pericyte function during luteal angiogenesis remains to be determined.  However, we have 
demonstrated that Notch signaling is essential for pericyte function and the role of Notch in 
pericyte/endothelial cell interactions deserves closer attention in order to expand our 






































































Figure 2. Analysis of expression of mural cell markers in the corpus luteum. Pericytes 
lining the CD31-positive capillaries (green) of the corpus luteum are positive for NG2 (A), 
PDGFR-β (B) and desmin (C). αSMA expression is restricted to the mural cells lining the theca 
blood vessels (D). DAPI in blue. Scale bars; 100 μm.
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Notch3 αSMA Notch3 / αSMA Notch3 / αSMA / DAPIC
Figure 3. Luteal pericytes express Notch1 and Jagged1, but not Notch3. Sections of 
ovaries isolated from pre-pubescent female mice stimulated with gonadotropins to induce 
ovulation were stained for NG2 (green) and Notch1 (A) or NG2 (green) and Jagged1 (B) or     
αSMA (green) and Notch3 (C). A subset of NG2-positive pericytes in the CL express Notch1 
(arrowheads). Jagged1 expression is observed in NG2-positive pericytes in the CL (arrows).   
Notch3 is not expressed at detectable levels by luteal pericytes. DAPI staining shows nuclei in 
blue. Scale bars; 50 μm (A and B), 100 μm (C).
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Figure 4. Structure of the jagged inhibitor, N110-24 decoy. The extracellular domain of 
human NOTCH1 is composed of 36 EGF-like repeats (A). Full-length Notch decoy expresses 
the entire extracellular domain of human NOTCH1 and binds delta-like and jagged ligands to 
inhibit all Notch signaling (B). The N110-24 decoy is composed of EGF-like repeats 10-24 and 
specifically binds jagged ligands (C).  Notch decoy variants are fused to human IgG Fc. EGF: 
epidermal growth factor, LNR: LIN-12/Notch repeats, TM: transmembrane domain, ANK: 
ankyrin repeats, PEST: proline [P], glutamic acid [E], serine [S], and threonine [T] degradation 
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Figure 5. Assessment of N110-24 decoy treatment following controlled hormonal 
stimulation of ovulation. Western blot for human Fc following injection of adenovirus 
expressing human Fc (A). Sexually immature female mice were injected with 5 i.u. PMSG  and 
5 i.u. hCG to induce controlled ovulation, adenovirus is injected on day 1 (B). At day 4, western 
blot for human Fc shows high levels of serum Fc (approximately 30 kD) in the control group 
and high serum levels of N110-24 decoy (approximately 140 kD) in the experimental group (C). 
H&E staining of ovary sections shows that ovulation occurs normally in the N110-24 decoy 
treated group (D). Ovaries isolated from N110-24 decoy treated mice are smaller in weight 
following controlled hormonal stimulation (E). Quantification of CL number (F) and CL develop-
ment (G) shows no significant difference between treatment groups. n=4, 2 ovaries/mouse. 






























Figure 6. Analysis of luteal vascularization with N110-24 decoy treatment following con-
trolled stimulation of ovulation. Sections of ovaries from human Fc and N110-24 decoy 
treated mice stained for the endothelial marker CD31 (red) and DAPI (blue) to show total cell 
content of the CL (A). Quantification of CL vessel content as measured by CD31 staining 
normalized to DAPI to control for differences in CL progression (B). n=4, 2 ovaries/mouse, 2 































































Figure 7. Analysis of luteal pericyte content with N110-24 decoy treatment following 
controlled stimulation of ovulation. Ovary sections fluorescently stained for CD31 (red), the 
pericyte marker NG2 (green) and DAPI (blue) (A). Quantification of luteal NG2 staining 
normalized to DAPI shows that N110-24 decoy inhibits pericyte recruitment to the CL (B), but 
luteal vessels have normal pericyte coverage (C). n=4, 2 ovaries/mouse, 2 sections/ovary.  


































































Hormonal Hyperstimulation of Ovulation
Figure 8. Assessment of hyperstimulated ovaries isolated from mice treated with 
N110-24 decoy. 20 i.u. PMSG and 20 i.u. hCG injected i.p. causes ovarian hyperstimulation (A).  
Western blot for human Fc shows high serum levels of Fc in the control group and high serum 
levels of N110-24 decoy in the experimental group at time of ovary collection (B). Gross pictures 
show hemorrhaging in hyperstimulated ovaries isolated from Ad-N110-24 decoy treated female 
mice (C). Quantification of ovarian weight at time of collection (D). H&E staining of ovaries 
show hemorrhaging of corpora lutea with N110-24 decoy treatment (E). Quantification of normal 
and hemorrhaging corpora lutea (F). n=4, 2 ovaries/mouse. Error bars represent SD of the 


































































Figure 9. Vascular analysis of corpora lutea following ovarian hyperstimulation and  
N110-24 decoy treatment. Ovary sections fluorescently stained for CD31 (red), NG2 (green) 
and DAPI (blue) to visualize endothelial cells, pericytes, and cell nuclei, respectively (A-G).  
Quantification of luteal vascular content normalized to total luteal cell content (H). Quantifica-
tion of luteal pericyte content normalized to total luteal cell content (I). n=4, 1 ovary/mouse, 2 














Figure 10. αSMA expression is reduced in N110-24 decoy-treated, hyperstimulated ova-
ries. Ovary sections fluorescently stained for αSMA (red) show reduced αSMA expression in 
the ovarian theca of N110-24 decoy treated female mice, as compared to control. DAPI staining 


































Figure 11. Pericyte association with luteal vessels is compromised in N110-24 decoy 
treated mice with ovarian hyperstimulation. High magnification confocal stacks of non-
hemorrhaged corpora lutea of Fc-treated (A) and N110-24 decoy treated (B) mice. Ovaries 
fluorescently stained for CD31 (red) to visualize the endothelium, NG2 (green) to mark peri-
cytes, and DAPI (blue) for visualization of cell nuclei. Zoomed images of areas marked by 
white boxes in A and B allow for closer assessment of pericyte association with the vascula-
ture (C-F). Arrowheads show pericytes that are poorly associated with endothelial cells in the 






































Figure 12. Analysis of vessel structure in hemorrhaging corpora lutea of mice treated 
with N110-24 decoy. High magnification confocal stacks of hemorrhaging corpora lutea stained 
for CD31 (red), NG2 (green), and DAPI (blue) of control (A) and N110-24 decoy treated (B) 
female mice with hormonal hyperstimulation of ovulation. A yellow “H” marks the hemorrhagic 
core of the CL and a dotted white line shows the periphery of the CL. Zoomed pictures of 
areas marked by white boxes (C-F). Arrows mark dilated capillaries, arrowheads mark dissoci-
ating pericytes, and asterisk shows vessel with discontinuous endothelial cell lining in the 




























To date, the study of Notch signaling in mural cells has primarily focused on the role of 
Notch in vascular smooth muscle cell (VSMC) differentiation and function.  In part this derives 
from the fact that human NOTCH3 mutations are associated with a disease state involving 
VSMCs.  Mutations in Notch3 cause cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy (CADASIL)18.  CADASIL is the most commonly inherited 
stroke disease in humans and is characterized by degeneration of the VSMC lining of small and 
medium-sized blood vessels leading to cerebral vessel dysfunction, ischemic stroke, and 
premature death.  The pathology of CADASIL underlines the important role Notch3 plays in 
VSMC function, and thus has spurred extensive research in understanding Notch in VSMCs.  
However, Notch is also expressed by pericytes, the mural cells lining capillaries and small 
arterioles and venules.  Whereas VSMCs regulate vascular contractility, pericytes fulfill a more 
active role in angiogenesis because of their association with sprouting and remodeling capillary 
endothelial cells.  Since pericytes and VSMCs have distinct functions in the vasculature, the role 
of Notch signaling may also be different in these two mural cell types.  
 Of the four Notch receptors found in mammals, VSMCs express Notch1, Notch2, and 
Notch3108.  Endothelial cells and vascular smooth muscle cells express the Notch ligand 
Jagged1 allowing for cell autonomous and cell non-autonomous activation of VSMC Notch 
signaling.  Notch promotes VSMC differentiation to a contractile mature cell phenotype by 
inducing expression of contractile proteins, such as α-smooth muscle cell actin (αSMA), 
smoothelin and myosin light chain kinase (MLCK)23,32,35.  
In VSMCs Notch induces expression of the receptor tyrosine kinase PDGFR-β22.  
PDGFR-β is expressed by pericytes and VSMCs.  PDGF-B, the ligand for PDGFR-β, is 
expressed and secreted as a homodimer (PDGF-BB) by endothelial tip cells during 
angiogenesis to attract pericytes to the nascent sprout13.  When activated by ligand binding, 
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PDGFR-β promotes cellular proliferation, survival and migration4,109. Mice mutant for PDGF-B or 
PDGFR-β die perinatally due to severe hemorrhaging caused by a lack of mural cell coverage in 
a variety of vascular beds4,7,67.  Interestingly, when Notch is activated in VSMCs, migration 
toward PDGF-BB is inhibited despite increased PDGFR-β expression22.  This suggests that 
Notch promotion of VSMC differentiation for contractile function overrides the chemotactic 
response provided by increased PDGFR-β in these mature VSMCs.  
 It has been proposed that mural cells associated with different types of vessels fall along 
a continuum of cellular differentiation5.  This theory posits that pericytes are undifferentiated and 
“plastic” vascular cells as compared to the contractile mature VSMCs that make up the tunica 
media of large arteries (See Chapter 1 for detailed review).  Notch has been shown to promote 
contractile VSMC differentiation, however Notch inhibits fibroblast differentiation to a vascular 
smooth muscle cell fate110.  Since Notch signaling fulfills different functions during different 
stages of mural cell differentiation and as it is not clear how Notch functions in pericytes, we 
investigated the role of Notch in pericytes. We found that Notch promoted PDGFR-β expression 
in pericytes, similar to VSMCs.  Unlike VSMCs, Notch signaling promotes cell migration toward 
PDGF-BB in pericytes.  
 
RESULTS 
Analysis of Notch signaling in cultured pericytes 
We analyzed Notch signaling in primary human brain vascular pericytes (HBVP) isolated 
from the brain microvasculature.  This pericyte line has successfully been used in endothelial 
cell/pericyte network formation assays developed by the Davis lab65.  Using a similar co-culture 
assay, the Davis lab reports that VSMCs fail to support endothelial tube formation, as is seen 
when using HBVP, demonstrating that pericytes and VSMCs have distinct phenotypes when 
grown in association with isolated endothelial cells (Davis lab, unpublished data).   
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 VSMCs express Notch1, Notch2, Notch3, and the Notch ligand Jagged1108.  We 
analyzed Notch receptor and ligand gene expression in HBVP and compared expression levels 
to human umbilical venous endothelial cells (HUVEC).  HBVP express NOTCH1, NOTCH2, and 
NOTCH3, whereas HUVEC express NOTCH1, NOTCH2, and NOTCH4 (Figure 1).  Both 
HUVEC and HBVP also express high levels of JAGGED1, whereas DLL4 is expressed at a 
significantly higher level in HUVEC.  JAGGED2 is not expressed by HUVEC or HBVP (data not 
shown).  Thus, cultured pericytes have a similar Notch receptor and ligand gene expression 
profile to VSMCs and do not express high levels of endothelial specific genes, Dll4 and Notch4. 
 We next determined if Notch signal activation in pericytes increased expression of Notch 
target gents by analyzing expression of HES/HEY genes in HBVP expressing activated forms of 
Notch.  The Notch intracellular domain-containing transcriptional complex promotes transcription 
of a variety of gene targets including the HES and HEY transcriptional repressors (see Chapter 
1 for detailed review).  Co-culture of VSMCs with endothelial cells has been shown to induce 
VSMC Notch signaling and subsequent expression of HEYL and HES1106.  To activate Notch in 
pericytes, we infected HBVP with adenovirus expressing the intracellular domain of Notch1 (Ad-
N1IC). Notch signal activation in pericytes induced expression of HEY1, HEYL, HES1, and 
HES5 (Figure 2).  HEYL was the most strongly induced gene analyzed, suggesting that HEYL 
may be an important downstream target of Notch in pericytes. This data demonstrated that 
Notch activation induces the expression of canonical Notch targets in cultured pericytes.   
 
Notch inhibits endothelial PDGF-B expression and promotes PDGFR-β expression in 
pericytes 
 PDGFR-β is a direct gene target of Notch1 and Notch3 in cultured vascular smooth 
muscle cells22.  Since we showed that Notch signals in pericytes, we wanted to see if Notch 
signaling also regulates PDGFR-β expression in pericytes.  We analyzed pericytes with 
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activated Notch1 and activated Notch3 and found that both Notch1 and Notch3 induced 
PDGFR-β expression in pericytes (Figure 3A).  When analyzing human umbilical venous 
endothelial cells (HUVEC) with active Notch signaling we observed that activated Notch1 (N1IC) 
and activated Notch4 (Notch4/int3) repressed expression of PDGF-B, the ligand for PDGFR-β 
(Figure 3C).  This data fits with current models where Notch functions during sprouting 
angiogenesis by being active in stalk endothelial cells while Notch signaling is low in endothelial 
tip cells.  In addition, in endothelial tip versus stalk cell differentiation PDGF-B has been shown 
to be strongly expressed by endothelial tip cells during sprouting angiogenesis111.  Thus, our 
findings are consistent with increased PDGF-B levels being associated with tip cells where 
Notch activity is low.  We propose that Notch regulates the PDGFR-β signaling pathway by 
repressing endothelial PDGF-B expression and inducing PDGFR-β expression in pericytes.  
 
Notch signaling in pericytes is necessary for PDGFR-β expression and reduced Notch 
signaling impairs PDGF-BB directed pericyte migration 
To further characterize the role of Notch in PDGFR-β signaling, we inhibited Notch 
signaling in pericytes and analyzed PDGFR-β protein expression.  HBVP were treated with 
increasing concentrations of the γ-secretase inhibitor, compound E, which blocks proteolytic 
cleavage of the Notch proteins and thus inhibit nuclear translocation of the Notch intracellular 
domain.  Consequently, compound E inhibits all canonical Notch signaling.  We observed a 
dose dependent inhibition of PDGFR-β protein expression with exposure to increasing 
concentrations of compound E (Figure 4A).  This data demonstrates that Notch signaling is 
required in pericytes to maintain PDGFR-β expression. 
 To determine if reduced PDGFR-β expression caused by compound E treatment alters 
pericyte function we analyzed the effects of compound E on PDGF-BB directed pericyte 
invasion and migration (Figure 4B).  We used compound E at a concentration of 200 μM where 
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we observed the greatest inhibition of PDGFR-β expression, without significant effects on 
pericyte viability.  In untreated pericytes, PDGF-BB increased pericyte migration through 
Matrigel, as compared to serum free media (SFM).  Inhibition of Notch signaling by compound E 
treatment completely inhibited pericyte migration in SFM and dramatically reduced their 
migration through Matrigel toward PDGF-BB.  Thus, Notch signaling in pericytes promotes 
pericyte migration and invasion through Matrigel towards PDGF-BB.  Furthermore, this data 
suggests that Notch regulates pericyte function by promoting PDGFR-β expression. 
 
Combined inhibition of Notch1 and Notch3 alters pericyte morphology and reduces 
PDGFR-β expression 
 In VSMCs, both Notch1 and Notch3 have been shown to promote PDGFR-β 
expression22.  To specifically analyze the role of Notch1 and Notch3 in regulating pericyte 
PDGFR-β expression we made HBVP cell lines with Notch1 knockdown, Notch3 knockdown, or 
combined knockdown of Notch1 and Notch3 using shRNA.  HBVP cell lines with Notch1 
knockdown appeared morphologically similar to control (Figure 5B) and had a similar rate of 
growth as control HBVP (data not shown).  HBVP cell lines with Notch3 knockdown displayed 
altered cell morphology characterized by cellular elongation and an increased number of cellular 
processes (Figure 5C).  Knockdown of Notch3 modestly reduced cell proliferation (data not 
shown).  Knockdown of both Notch1 and Notch3 dramatically affected pericyte morphology and 
viability (Figure 5D).  Combined reduction of Notch1 and Notch3 caused cellular enlargement, 
decreased cell attachment, and inhibited proliferation, suggesting that both Notch1 and Notch3 
are required for normal pericyte function and that some Notch expression is required for pericyte 
viability. 
 We hypothesized that the observed defects in pericyte proliferation and viability 
observed when both Notch1 and Notch3 were inhibited may be due to reduced PDGFR-β 
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expression.  We compared PDGFR-β protein expression in HBVP cell lines with NOTCH1 
knockdown, NOTCH3 knockdown, and combined knockdown of NOTCH1 and NOTCH3 (Figure 
5E).  We observed that HBVP with reduced NOTCH1 or NOTCH3 displayed decreased 
PDGFR-β protein levels, as compared to control.  However, combined knockdown of NOTCH1 
and NOTCH3 resulted in a dramatic reduction of PDGFR-β protein expression, as compared to 
control or either NOTCH1 knockdown or NOTCH3 knockdown alone.  This data suggests that 
Notch1 and Notch3 both contribute to PDGFR-β expression in cultured pericytes to promote 
proper cell function and viability.   
 
Pericyte expression of N11-36 decoy inhibits endothelial network formation 
Inhibition of Notch signaling dramatically affected cellular function of pericytes cultured 
alone in a monolayer.  However, culturing pericytes alone does not adequately recapitulate 
physiological conditions since in vivo pericytes are found in close association with endothelial 
cells.  Endothelial cell/pericyte co-culture experiments have demonstrated that endothelial 
Jagged1 initiates a positive feedback loop in pericytes where Notch3 activation induces 
Jagged1 and Notch3 expression in VSMCs106.  Since pericytes are critical regulators of 
angiogenesis and endothelial cells have been shown to induce Notch signaling in VSMCs, we 
wanted to analyze endothelial network formation in the presence of pericytes when Notch 
signaling is inhibited.  To inhibit Notch signaling we made HBVP cell lines that express the pan 
Notch ligand inhibitor Notch1 decoy (N11-36 decoy) developed in our lab from the extracellular 
domain of rat Notch1105.  We previously established that the N11-36 decoy blocks Jagged and 
Delta-like ligands from activating Notch signaling105.  Endothelial cells (HUVEC) expressing RFP 
(red) were embedded in a collagen gel with control HBVP or HBVP expressing N11-36 decoy.  
After 7 days, robust endothelial networks can be observed when HUVEC are co-cultured with 
control HBVP (Figure 6A).  However, endothelial network formation is dramatically reduced 
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when HUVEC are co-cultured with pericytes expressing N11-36 decoy (Figure 6B).  Furthermore, 
network formation over time is reduced in the presence of HBVP expressing N11-36 decoy 
(Figure 6C).  This data fits in vivo findings from our lab that demonstrated that treatment with full 
length N1 decoy inhibits tumor angiogenesis and developmental retinal angiogenesis 
(Kangsamaksin, T., et al., unpublished data).  This is the first evidence to show that N11-36 
decoy expression by pericytes can inhibit endothelial cell network formation.   
 
DISCUSSION 
We demonstrated that Notch signaling regulates the PDGF-B/PDGFR-β signaling 
pathway in vitro.  Inhibition of Notch signaling using compound E or shRNA-targeted reduction 
of Notch1 and Notch3 transcripts caused reduced PDGFR-β expression in pericytes.  In 
cultured endothelial cells, Notch activation inhibited PDGF-B expression, the ligand for PDGFR-
β.  In addition, we observed reduced PDGF-BB directed migration in pericytes with reduced 
canonical Notch signaling.  The functional consequence of Notch inhibition was evaluated where 
endothelial network formation was impaired when HUVEC were cultured with pericytes 
expressing Notch1 decoy to inhibit Notch signaling.  
Notch has primarily been studied in more mature vascular smooth muscle cells.  Our 
data expands the role of Notch in regulating mural cell function to the pericyte.  In line with the 
VSMC Notch expression profile, cultured pericytes express Notch1 and Notch3 and the Notch 
ligand, Jagged1.  Notch induces PDGFR-β expression in vascular smooth muscle cells22.  We 
showed that Notch induces PDGFR-β expression in pericytes.  Our work demonstrated that 
Notch signaling promotes PDGF-BB directed pericyte migration, whereas Notch inhibits PDGF-
BB directed migration in VSMCs, despite increased levels of PDGFR-β.  This difference in 
cellular function in response to Notch may reflect the different functional requirements for VSMC 
and pericytes.  By inducing expression of contractile proteins in VSMCs, Notch regulates VSMC 
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differentiation to a contractile and more mature mural cell phenotype72,108.  Differentiation and 
maturation of VSMCs requires that cells cease to proliferate and migrate.  Thus, to promote 
cellular differentiation, Notch may inhibit VSMC migration despite increased PDGFR-β 
expression.  Our data suggests that Notch has a unique role in pericytes where instead of 
regulating cell differentiation, we believe Notch functions to promote PDGFR-β induced cell 
migration in pericytes. 
In VSMCs, PDGFR-β has been shown to be a direct target of Notch1 and Notch3.  
However, it has been demonstrated that Notch1 and Notch3 bind distinct cis-elements in the 
PDGFR-β promoter showing that they independently regulate PDGFR-β11,22.  We showed that 
combined deficiency of Notch1 and Notch3 reduced PDGFR-β protein levels in cultured 
pericytes to a greater extent than inhibition of Notch1 or Notch3 alone.  This data suggests that 
both Notch1 and Notch3 are required in pericytes for proper PDGFR-β expression and normal 
pericyte function.  We showed that inhibition of Notch1 in pericytes is sufficient to cause 
decreased PDGFR-β expression providing additional evidence for a role for Notch1 in regulating 
mural cell function.  Notch1 and Notch3 may have distinct functions in mural cells.  In fact, it is 
possible that the balance of Notch1 and Notch3 may contribute to differing mural cell 
phenotypes and cell differentiation.  Future experiments focusing on the distinct roles of Notch1 
and Notch3 signaling in VSMCs versus pericytes will help define unique mural cell phenotypes 
and functions.  
We conclude that Notch has different functions in pericytes and VSMCs. It is well 
established that pericytes and VSMCs fulfill unique roles in the vasculature.  Unlike VSMCs, 
pericytes line small blood vessels and capillaries where they share a basement membrane with 
the endothelium. Thus, pericytes have an intimate relationship with endothelial cells during 
angiogenesis and in the quiescent vasculature.  Our data shows that despite similarities in 
VSMC and pericyte Notch expression, Notch signaling results in different functional outcomes in 
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pericytes than it does in VSMCs.  These findings help to define pericytes and VSMCs as unique 



















































NOTCH1 (302 bp) 
NOTCH2 (457 bp) 
NOTCH3 (352 bp) 
NOTCH4 (354 bp) 
DLL4 (348 bp) 
JAGGED1 (386 bp) 
HUVEC HBVP
Figure 1. Notch receptor and ligand expression in human brain vascular pericytes. mRNA 
expression of Notch receptors and ligands in human umbilical venous endothelial cells 
(HUVEC) and human brain vascular pericytes (HBVP). Size of amplicon in base pairs (bp) 

















































































Figure 2. Notch activation induces HEY1, HEYL, HES1, and HES5 expression in HBVP. 
HBVP were infected with adenovirus expressing the intracellular domain of Notch1 (Ad-N1IC) or 
Fc (Ad-Fc) as control.  Quantitative RT-PCR on HBVP cDNA. Error bars represent standard 
deviation. * p<0.05, **p<0.005.
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Figure 3. Notch inhibits PDGF-B in HUVEC and induces PDGFR-β in pericytes. 
Quantitative RT-PCR to analyze relative gene expression. Analysis of PDGFR-β gene 
expression in HBVP cell lines expressing activated Notch1 (N1IC), activated Notch3 (N3IC) or 
GFP as control (A). Increased levels of the downstream Notch target HEYL validates Notch 
activation in HBVP cell lines (B). HUVEC cell lines expressing N1IC, activated Notch4 (N4/int3) 
or Fc as control. HUVEC with activated Notch display reduced PDGF-B transcript levels (C). 
Validation of activation of Notch; HUVEC-N1IC have increased NOTCH1 transcript levels and 




































































































































Figure 4. Inhibition of Notch signaling in pericytes inhibits PDGF-BB directed migration. 
Western blot for PDGFR-β and NG2 in pericytes treated with increasing concentrations of 
compound E (A). Vinculin is used as a loading control. Pericytes treated with compound E 
display reduced Matrigel invasion in serum free media (SFM) and in media containing 20 ng/μl 
human recombinant PDGF-BB (B).  
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Figure 5. Analysis of pericyte cell lines with combined knockdown of NOTCH1 and 
NOTCH3. Analysis of cell morphology of HBVP cell lines made using lentiviral constructs 
expressing scrambled shRNA (control), human NOTCH1-shRNA (N1 knockdown), human 
NOTCH3-shRNA (N3 knockdown), and both NOTCH1-shRNA and NOTCH3-shRNA (N1/N3 
knockdown) (A-D). Corresponding western blot for PDGFR-β on cell lysates isolated from 














Figure 6. The pan Notch ligand inhibitor, N11-36 decoy inhibits network formation in a 
pericyte/endothelial cell co-culture assay. Endothelial cells expressing RFP were embed-
ded in a 2.5 mg/ml collagen gel with HBVP lentivirally infected with full-length rat Notch1 
extracellular domain (N11-36 decoy) or HBVP expressing GFP, as control. Endothelial network 
formation is shown in red. After 7 days, inhibition of Notch signaling with N11-36 decoy inhibits 
endothelial network formation, as compared to control (A and B). An equivalent number of 
endothelial cells are present at Day 1 in both experimental groups, however network forma-
tion is inhibited over time, as shown at Day 5 and Day 7 when endothelial cells are 































Here we demonstrate a novel role for Notch in angiogenesis where it signals in pericytes 
to regulate endothelial cell sprouting, vessel maturation and vascular function.  We showed that 
both Notch1 and Notch3 are required to promote pericyte recruitment and association with the 
endothelium during angiogenesis and that these processes depend upon Jagged activation of 
Notch.  We also showed that loss of proper pericyte/endothelial cell association due to Notch 
deficiency results in dramatic vascular anomalies including increased vessel density, vessel 
enlargement, increased vascular permeability, and arteriovenous malformations.  We also 
demonstrated that Notch signaling has unique functional outcomes in pericytes, as compared to 
previous reports of Notch function in vascular smooth muscle cells.  Our work expands the role 
of Notch signaling in angiogenesis while demonstrating the critical role pericytes play in 
regulating endothelial function.   
 
Notch regulates pericyte recruitment during angiogenesis 
We showed that Notch1+/-, Notch3-/-, Notch1+/-;Notch3+/-, and Notch1+/-;Notch3-/- mice 
displayed reduced pericyte coverage during retinal angiogenesis.  We postulated that there 
were two possible causes for decreased pericyte coverage of the vasculature: 1) Notch 
deficiency impairs pericyte recruitment to new blood vessels, 2) Notch deficiency causes 
reduced pericyte viability.  Analysis, of cleaved-caspase 3 staining in the retina to assess for 
apoptosis showed no difference in pericyte apoptosis in the mouse mutants analyzed (data not 
shown).  Thus, we concluded that Notch does not affect pericyte viability in the retina.   
During angiogenesis, endothelial cells recruit pericytes by secreting PDGF-B, which 
signals through PDGFR-β expressed by pericytes to induce their proliferation and migration to 
new blood vessels.  Ablation of PDGF-B/PDGFR-β signaling in the mouse reduced brain 
pericyte content by approximately 95% demonstrating that this signaling pathway is critical for 
pericyte recruitment in the central nervous system4,112.  We established that Notch signaling 
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regulates PDGFR-β expression in cultured human brain pericytes.  We also showed that Notch 
signaling inhibits PDGF-B expression in endothelial cells.  In the nascent angiogenic sprout, it 
has been established that Notch1 regulates endothelial tip versus stalk cell identity.  This model 
centers on the fact that Notch1 inhibits VEGFR-2 expression where endothelial tip cells express 
low levels of Notch1 and high Dll4 to allow for high VEGFR-2 expression and thus induction of a 
migratory and highly VEGF-responsive cellular phenotype71.  High Dll4 in the tip cell can then 
activate Notch1 signaling in the neighboring endothelial stalk cell to inhibit sprouting of the stalk 
cell through downregulation of VEGFR-2.  PDGF-B is also expressed at high levels by 
endothelial tip cells where it is secreted to induce pericyte recruitment to nascent angiogenic 
sprouts13.  We demonstrated that Notch1 inhibits PDGF-B expression in endothelial cells.  This 
new data can be used to refine the model describing the role of Notch in sprouting angiogenesis 
to include its function in regulating the PDGF-B/PDGR- β signaling pathway (Figure 1).  Our 
model proposes that low Notch1 levels in the endothelial tip cell of an angiogenic sprout allows 
for increased PDGF-B expression, whereas Dll4-induced Notch signaling in the neighboring 
stalk cell represses PDGF-B expression by the stalk cell.  Notch-mediated repression of PDGF-
B sets that stage for Notch1 signaling to establish an extracellular gradient of high PDGF-BB 
surrounding the tip cell and lower PDGF-BB along the stalk cell to guide pericyte migration 
along the endothelial sprout.  To expand the role of Notch in pericyte recruitment, we also 
demonstrated that Notch induces PDGFR-β expression in pericytes and that Notch signaling is 
required for PDGF-BB directed pericyte migration in vitro.  Thus, we propose that Notch 
regulates pericyte recruitment in two ways; by establishing a PDGF-BB gradient for migrating 
pericytes to follow and by enhancing pericyte response to PDGF-BB through induction of 
PDGFR-β expression.  
The validity of our proposed model for Notch regulation of PDGF-B/PDGFR-β during 
angiogenesis remains to be assessed in vivo.  We have stained Notch1/Notch3 mutant P5 
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retinas for PDGFR-β protein expression.  Careful assessment of different vascular areas of 
wholemount retinas stained for PDGFR-β did not show a significant difference in PDGFR-β 
expression levels across genotypes (data not shown).  However, it is possible that antibody 
staining of wholemount retinas is not sensitive enough to detect mild decreases in PDGFR-β 
protein levels, which could still result in impaired pericyte recruitment.  Assessment of retinal 
PDGFR-β mRNA levels could provide for greater sensitivity.  Assessment of PDGF-BB 
expression by the endothelium in Notch mutant mice would also be of value.  Our model 
suggests that mice with Notch1 haploinsufficiency would display increased endothelial PDGF-B 
expression.  One would expect that increased PDGF-BB levels would cause increased pericyte 
recruitment, however we observed decreased pericyte recruitment in mice with Notch1 
heterozygosity.  Despite increased PDGF-BB levels, we believe that reduced PDGFR-β 
expression due to Notch deficiency in the pericyte could cause a defect in pericyte recruitment 
in Notch1 heterozygous mice.  Furthermore, from our model Notch1 deficiency would also 
disrupt PDGF-BB gradient formation, which could hinder pericyte recruitment despite increased 
PDGF-BB levels in Notch1+/- mice.   
 
A role for Notch in pericyte maturation 
Pericytes and vascular smooth muscle cells are collectively referred to as mural cells 
because they both contribute to the vessel wall.  However, pericytes and VSMCs perform very 
different functions in the vasculature.  VSMCs are contractile cells that line larger vessels to 
regulate vessel tone through modulation of vasodilation and vasoconstriction.  In contrast, 
pericytes function to promote vessel stability and inhibit vascular permeability of small vessels 
and capillary networks.  A current theory proposes that pericytes and vascular smooth muscle 
cells fall along a continuum of mural cell differentiation where pericytes are considered 
immature, undifferentiated mural cells that are capable of maturing into contractile terminally 
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differentiated VSMCs5.  Identification of mural cells lining medium sized vessels that display an 
intermediate cellular phonotype with characteristics of both pericytes and VSMCs supports this 
theory.  An opposing theory could postulate that pericytes and VSMCs are distinct cell types 
with distinct origins that undergo distinct maturation events.   
Mural cell maturation can be defined as the phenotypic changes that allow for different 
types of mural cells to fulfill their specific function in the fully developed vasculature.  
Accordingly, maturation allows for VSMCs to be contractile and pericytes to appropriately 
support and associate with the microvascular endothelium.  Notch regulates VSMC maturation 
by inducing expression of contractile proteins113.  Mouse models with altered Notch signaling in 
vascular smooth muscle cells display phenotypes associated with impaired VSMC function, 
such as vessel dilation and decreased vascular tone32,34,36.  We propose that pericyte maturation 
involves cellular events that transform the migratory and proliferative pericyte into a cell that 
ceases migration and instead associates with the endothelium to promote vessel stability and 
quiescence.  We observed loss of pericyte association with the retinal endothelium in Notch1+/-
;Notch3-/- mice, and thus concluded that pericyte maturation was impaired in this mouse model.   
Impaired pericyte maturation in mice deficient for Notch caused alterations in basement 
membrane deposition and a destabilized capillary network.  Our work supports a role for Notch 
in regulating pericyte maturation that is independent from its role in promoting VSMC 
differentiation and suggests that Notch has distinct roles in distinct mural cell populations.  
Furthermore, our findings suggest that pericytes and VSMCs are distinct cell types that undergo 
independent maturation events to fulfill their functional role in the vasculature.   
In the CNS, pericytes are a critical component of the blood-brain barrier, which regulates 
molecular transport across and between endothelial cells.  Loss of pericyte coverage in the CNS 
leads to increased vascular permeability and vessel dysfunction due to impaired blood-brain 
barrier function69,70.  Loss of pericyte coverage is also associated with several vascular 
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diseases, such as stroke and diabetic retinopathy5.  In diabetic retinopathy, pericyte dissociation 
precedes vascular abnormalities and retinal neuronal death114.  In mouse models of ischemic 
stroke, blood-brain barrier function is impaired and ischemia can induce pericyte dissociation 
and migration away from the cerebral vaculature115.  The vascular dysfunction that accompanies 
pathologies associated with pericyte loss demonstrates the critical role mature pericytes play in 
maintaining vessel barrier function and vascular stability.  The vascular phenotypes we 
observed in Notch1+/-;Notch3-/- mice, such as increased vessel permeability and altered 
basement membrane deposition suggest that a functional blood-retinal barrier is not established 
in this mouse model.  Our data suggests that Notch signaling in the pericytes may be altered in 
the aforementioned vasculopathies.  Future experiments that investigate the role of Notch 
signaling in pericyte function in the blood-brain barrier and retina-blood barrier could provide 
novel therapeutic targets for cerebral and retinal vasculopathies.   
 
Notch signaling produces divergent phenotypes in the pericyte 
We showed that Notch promotes both pericyte recruitment and pericyte maturation.  
These findings suggest that Notch signaling regulates two distinct pathways in pericyte function 
leading one to question how Notch functions in the same cell to regulate divergent phenotypes.  
The nature of Notch signaling allows for it to be temporally regulated in a highly dose dependent 
manner20.  Jagged1 activation of Notch3 in VSMCs has been shown to induce a positive 
feedback loop that induces Jagged1 and Notch3 expression in the VSMC, thus amplifying Notch 
signaling in the mural cell compartment106.  In the pericyte, Notch signaling can be activated by 
multiple ligands expressed by the vasculature including Dll1, Dll4, and Jagged1.  Activation of 
Notch through different Notch ligands has been shown to induce different functional outcomes in 
endothelial cells where Dll4 activation of Notch promotes endothelial cell sprouting and instead 
Jagged1 inhibits endothelial cell sprouting (Kangsamaksin T., at al., unpublished data)37.  
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Activation of Notch signaling by different ligands may similarly result in different pericyte 
phenotypes.  One can postulate that Notch signaling levels may differ in pericytes that are 
migrating versus those associated with the endothelium.  A migratory pericyte may be exposed 
to high levels of Jagged1 and Dll4 expressed by endothelial cells that are actively sprouting and 
expanding.  In contrast, endothelial cells undergoing lumenization and maturation may present 
the pericyte with a different ligand profile and thus induce a level of Notch signaling required for 
pericyte maturation.  Furthermore, pericytes that are associated with the endothelium have less 
contact with endothelial cells due to the basement membrane, again altering ligand exposure 
and changing the potential for Notch signaling in the pericyte.  Pericyte exposure to varying 
types and levels of Notch ligands may govern the different cellular phenotypes associated with 
Notch signaling and requires further investigation.   
 
Mural cell dysfunction contributes to AVMs 
We demonstrated that Notch1+/-;Notch3-/- mice develop arteriovenous malformations in 
the retina.  AVMs are vascular anomalies, which are characterized by unstable vessels that are 
prone to rupture, thus increasing the patients risk for stroke and death77,43.  Endothelial 
dysfunction has been implicated in the development of AVMs, however the pathogenesis of 
AVMs remains unclear86,116,117.  Since Notch3 is restricted to the mural cell compartment and 
Notch3-/- mice, as well as Notch1+/-;Notch3-/- mice display AVMs, our work supports a role for 
mural cells in AVM pathogenesis.  It has previously been shown that a subset of brain AVMs 
display decreased mural cell coverage79.  In Alk1 deficient mice that display impaired TGF-β 
signaling, AVMs developed following stimulation of angiogenesis through ectopic VEGF-A 
expression46.  The dysplastic vessels of these AVMs displayed loss of mural cell coverage with 
decreased PDGFR-β expression, providing additional evidence for mural cell dysfunction in the 
development of AVMs. 
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Before the appearance of AVMs in Notch1+/-;Notch3-/- mice we observed enlarged 
venules and increased vascular density as a result of pericyte dysfunction.  Improper pericyte 
association with the endothelium due to Notch deficiency resulted in impaired vascular 
differentiation into segregated arteriolar, venular, and capillary vascular structures.  Thus, we 
believe that arteriovenous shunts and AVMs arise as de novo vascular abnormalities in 
Notch1+/-;Notch3-/- mice due to alterations in the capillary network caused by pericyte 
dysfunction.  In humans, most brain AVMs are commonly believed to be congenital vascular 
abnormalities.  Our findings support a congenital origin for AVMs.  Furthermore, our data 
suggests that impaired pericyte function during the development of the circulatory system 
contributes to AVMs.  To determine if our findings in the mouse translate to the clinic, future 
studies should investigate pericyte coverage and pericyte Notch expression in human brain 
AVMs.   
 
A two-hit hypothesis for vessel dysfunction 
In humans, the inherited vascular disease hereditary hemorrhagic telangiectasia (HHT) 
is characterized by AVMs and caused by mutations in either ALK1 or ENG (the gene that 
encodes for endoglin) leading to impaired TGF-β signaling43.  Mouse models mutant for Alk1 do 
not develop congenital AVMs, but instead develop AVMs when exposed to ectopic VEGF-A or 
following wounding46.  From these findings, the authors proposed a two-hit hypothesis model for 
AVM development in HHT where both endothelial dysfunction and endothelial activation are 
required for AVMs to form.  
Notch1 inhibits VEGFR-2 expression in endothelial cells, therefore Notch1 
heterozygosity allows for increased endothelial VEGFR-2 expression and thus, endothelial 
activation.  Our data demonstrated that Notch3-/- mice displayed mural cell dysfunction and 
abnormal capillary beds.  However, additional loss of Notch1 in Notch1+/-;Notch3-/- mice caused 
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bona fide AVMs characterized by vascular tangles and arteriovenous shunts.  We believe that 
Notch1+/-;Notch3-/- mice develop AVMs due to pericyte dysfunction caused by Notch deficiency 
combined with endothelial activation caused by Notch1 heterozygosity.  Thus, we propose an 
alternative two-hit hypothesis model for AVM development where pericyte dysfunction and 
endothelial activation are both required for AVMs (Figure 2).  Analysis of AVMs in mice mutant 
for Notch3 with endothelial-specific deletion of Notch1 could address this hypothesis.   
In the ovary, pericyte dysfunction combined with endothelial activation also led to 
impaired vascular function.  Ovarian hyperstimulation is characterized by increased VEGF-A 
levels leading to an activated endothelium due to increased VEGFR-2 signaling107.  Jagged-
specific inhibition of Notch signaling with N110-24 decoy inhibited pericyte association with luteal 
vessels in the ovarian corpus luteum.  However, N110-24 decoy only caused luteal hemorrhaging 
in hyperstimulated ovaries, but not in ovaries that had undergone controlled stimulation of 
ovulation.  We believe that when endothelial cell function is properly regulated during 
angiogenesis, compensatory mechanisms enable a functional vascular network to form despite 
altered pericyte function.  However, when pericyte association with the endothelium is impaired 
and endothelial cells are excessively activated through increased VEGFR-2 signaling, severe 
vascular dysfunction ensues.  Accordingly, proper pericyte association with the endothelium is 
especially required during times of endothelial activation, such as inflammation and in tumor 
angiogenesis.  Thus, regulation of Notch function in pericytes could provide a novel target for 
diseases characterized by pathological angiogenesis.  
 
Conclusion  
Pericytes provide a unique function in angiogenesis by regulating endothelial cell 
sprouting and vessel maturation.  In quiescent vasculature, pericytes contribute to vessel 
permeability and stability.  We demonstrated that Notch signaling regulates pericyte recruitment 
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to nascent blood vessels.  We also showed that Notch is required for pericyte maturation to 
enable their association with the endothelium and that this process is critical for basement 
membrane deposition to promote vessel stabilization.  Pericyte dysfunction has been reported in 
vasculopathies such as diabetic retinopathy and stroke.  Our work demonstrates that altered 
pericyte function due to Notch deficiency also contributes to the development of arteriovenous 
malformations and loss of retina-blood barrier integrity.  Our works suggest that the role of 
Notch in pericyte/endothelial cell interactions is a previously unappreciated component of 


















































Figure 1. Notch regulation of PDGF-B/PDGFR-β signaling during angiogenesis.  Notch1 
inhibits PDGF-B expression in HUVEC.  Low levesl of Notch1 in the endothelial tip cell of an 
angiogenic sprout allows for high PDGF-B expression, whereas high Notch1 in the stalk cell 
inhibits PDGF-B expression in the stalk cell.  Differential Notch1 expression in tip versus stalk 
cells establishes a PDGF-BB gradiant to guide pericyte recruitment to nascent angiogenic 
sprouts.  In pericytes, Notch1 and Notch3 induce PDGFR-β expression to promote their 
migration during angiogenesis.  Endothelium shown in green, dotted white line is predicted 
















Figure 2. Pericyte dysfunction contributes to arteriovenous malformations.  A two-hit 
hypothesis for the formation of AVMs has been previously proposed where endothelial 
dysfunction (for example through Alk1 deficiency) combined with endothelial activation (by 
wounding or delivery of ectopic VEGF-A) are both required for the development of AVMS.  We 
propose an additional model where AVMs develop when pericyte dysfunction (by Notch 
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